-
1
-
-
1842349181
-
The direct effects of norepinephrine, epinephrine, and methoxamine on myocardial contractile force in man
-
1:CAS:528:DyaF3MXhtVSqsLo%3D 13706460
-
LI Goldberg RD Bloodwell E Braunwald AG Morrow 1960 The direct effects of norepinephrine, epinephrine, and methoxamine on myocardial contractile force in man Circulation 22 1125 1132 1:CAS:528:DyaF3MXhtVSqsLo%3D 13706460
-
(1960)
Circulation
, vol.22
, pp. 1125-1132
-
-
Goldberg, L.I.1
Bloodwell, R.D.2
Braunwald, E.3
Morrow, A.G.4
-
2
-
-
0141592830
-
Heart force effects of sympathomimetic amines as a basis for their use in shock accompanying myocardial infarction
-
1:CAS:528:DyaG2cXivFymsA%3D%3D 13106909
-
PC Gazes LI Goldberg TD Darby 1953 Heart force effects of sympathomimetic amines as a basis for their use in shock accompanying myocardial infarction Circulation 8 883 892 1:CAS:528:DyaG2cXivFymsA%3D%3D 13106909
-
(1953)
Circulation
, vol.8
, pp. 883-892
-
-
Gazes, P.C.1
Goldberg, L.I.2
Darby, T.D.3
-
3
-
-
77955675696
-
Comparative effects of a wide range of doses of L-epinephrine and of L-norepinephrine on the contractile force of the heart in situ
-
1:CAS:528:DyaG2MXlslOrsw%3D%3D 14392578
-
MD Cotten S Pincus 1955 Comparative effects of a wide range of doses of L-epinephrine and of L-norepinephrine on the contractile force of the heart in situ J Pharmacol Exp Ther 114 110 118 1:CAS:528:DyaG2MXlslOrsw%3D%3D 14392578
-
(1955)
J Pharmacol Exp Ther
, vol.114
, pp. 110-118
-
-
Cotten, M.D.1
Pincus, S.2
-
4
-
-
0000894064
-
Myocardial norepinephrine concentration in man. Effects of reserpine and of congestive heart failure
-
1:STN:280:DyaF2c%2FgvVGksg%3D%3D 14050968
-
CA Chidsey E Braunwald AG Morrow DT Mason 1963 Myocardial norepinephrine concentration in man. Effects of reserpine and of congestive heart failure N Engl J Med 269 653 658 1:STN:280:DyaF2c%2FgvVGksg%3D%3D 14050968
-
(1963)
N Engl J Med
, vol.269
, pp. 653-658
-
-
Chidsey, C.A.1
Braunwald, E.2
Morrow, A.G.3
Mason, D.T.4
-
5
-
-
0000274679
-
Cardiac norephinephrine stores in experimental heart failure in the dog
-
1:STN:280:DyaF2M%2FjvFamsg%3D%3D 14234835
-
CA Chidsey GA Kaiser EH Sonnenblick JF Spann E Braunwald 1964 Cardiac norephinephrine stores in experimental heart failure in the dog J Clin Invest 43 2386 2393 1:STN:280:DyaF2M%2FjvFamsg%3D%3D 14234835
-
(1964)
J Clin Invest
, vol.43
, pp. 2386-2393
-
-
Chidsey, C.A.1
Kaiser, G.A.2
Sonnenblick, E.H.3
Spann, J.F.4
Braunwald, E.5
-
6
-
-
0022980843
-
Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure
-
1:CAS:528:DyaL2sXkvVSgsw%3D%3D 2876788
-
MR Bristow R Ginsburg V Umans, et al. 1986 Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure Circ Res 59 297 309 1:CAS:528:DyaL2sXkvVSgsw%3D%3D 2876788
-
(1986)
Circ Res
, vol.59
, pp. 297-309
-
-
Bristow, M.R.1
Ginsburg, R.2
Umans, V.3
-
7
-
-
0027331367
-
Reduced beta 1 receptor messenger RNA abundance in the failing human heart
-
1:CAS:528:DyaK2cXnsVGltg%3D%3D 8254027
-
MR Bristow WA Minobe MV Raynolds, et al. 1993 Reduced beta 1 receptor messenger RNA abundance in the failing human heart J Clin Invest 92 2737 2745 1:CAS:528:DyaK2cXnsVGltg%3D%3D 8254027
-
(1993)
J Clin Invest
, vol.92
, pp. 2737-2745
-
-
Bristow, M.R.1
Minobe, W.A.2
Raynolds, M.V.3
-
8
-
-
0037049977
-
Cardiac excitation-contraction coupling
-
1:CAS:528:DC%2BD38Xms1Whsg%3D%3D 11805843
-
DM Bers 2002 Cardiac excitation-contraction coupling Nature 415 198 205 1:CAS:528:DC%2BD38Xms1Whsg%3D%3D 11805843
-
(2002)
Nature
, vol.415
, pp. 198-205
-
-
Bers, D.M.1
-
9
-
-
43549098268
-
Calcium cycling and signaling in cardiac myocytes
-
1:CAS:528:DC%2BD1cXkt1eqsbg%3D 17988210
-
DM Bers 2008 Calcium cycling and signaling in cardiac myocytes Annu Rev Physiol 70 23 49 1:CAS:528:DC%2BD1cXkt1eqsbg%3D 17988210
-
(2008)
Annu Rev Physiol
, vol.70
, pp. 23-49
-
-
Bers, D.M.1
-
10
-
-
0032102779
-
Cardiac protein phosphorylation: Functional and pathophysiological correlates
-
1:CAS:528:DyaK1cXktFKmurc%3D 9747427
-
ST Rapundalo 1998 Cardiac protein phosphorylation: functional and pathophysiological correlates Cardiovasc Res 38 559 588 1:CAS:528: DyaK1cXktFKmurc%3D 9747427
-
(1998)
Cardiovasc Res
, vol.38
, pp. 559-588
-
-
Rapundalo, S.T.1
-
11
-
-
0037081563
-
Protein phosphatase 1-targeted in many directions
-
1:CAS:528:DC%2BD38Xht1CmsrY%3D 11839776
-
PT Cohen 2002 Protein phosphatase 1-targeted in many directions J Cell Sci 115 241 256 1:CAS:528:DC%2BD38Xht1CmsrY%3D 11839776
-
(2002)
J Cell Sci
, vol.115
, pp. 241-256
-
-
Cohen, P.T.1
-
12
-
-
0346728803
-
Functional diversity of protein phosphatase-1, a cellular economizer and reset button
-
1:CAS:528:DC%2BD2cXotl2rtw%3D%3D 14715909
-
H Ceulemans M Bollen 2004 Functional diversity of protein phosphatase-1, a cellular economizer and reset button Physiol Rev 84 1 39 1:CAS:528: DC%2BD2cXotl2rtw%3D%3D 14715909
-
(2004)
Physiol Rev
, vol.84
, pp. 1-39
-
-
Ceulemans, H.1
Bollen, M.2
-
13
-
-
0033954554
-
Effects of serine/threonine protein phosphatases on ion channels in excitable membranes
-
1:CAS:528:DC%2BD3cXmtl2jtQ%3D%3D 10617768
-
S Herzig J Neumann 2000 Effects of serine/threonine protein phosphatases on ion channels in excitable membranes Physiol Rev 80 173 210 1:CAS:528:DC%2BD3cXmtl2jtQ%3D%3D 10617768
-
(2000)
Physiol Rev
, vol.80
, pp. 173-210
-
-
Herzig, S.1
Neumann, J.2
-
14
-
-
0036274039
-
Regulation of ryanodine receptors via macromolecular complexes: A novel role for leucine/isoleucine zippers
-
1:CAS:528:DC%2BD38XksFOis70%3D 12069756
-
AR Marks SO Marx S Reiken 2002 Regulation of ryanodine receptors via macromolecular complexes: a novel role for leucine/isoleucine zippers Trends Cardiovasc Med 12 166 170 1:CAS:528:DC%2BD38XksFOis70%3D 12069756
-
(2002)
Trends Cardiovasc Med
, vol.12
, pp. 166-170
-
-
Marks, A.R.1
Marx, S.O.2
Reiken, S.3
-
15
-
-
0242637601
-
What is the role of beta-adrenergic signaling in heart failure?
-
1:CAS:528:DC%2BD3sXoslykurk%3D 14615493
-
MJ Lohse S Engelhardt T Eschenhagen 2003 What is the role of beta-adrenergic signaling in heart failure? Circ Res 93 896 906 1:CAS:528:DC%2BD3sXoslykurk%3D 14615493
-
(2003)
Circ Res
, vol.93
, pp. 896-906
-
-
Lohse, M.J.1
Engelhardt, S.2
Eschenhagen, T.3
-
16
-
-
25144446880
-
Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy
-
1:CAS:528:DC%2BD2MXhtFOqsbfE 16124995
-
MA Movsesian MR Bristow 2005 Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy Curr Top Dev Biol 68 25 48 1:CAS:528:DC%2BD2MXhtFOqsbfE 16124995
-
(2005)
Curr Top Dev Biol
, vol.68
, pp. 25-48
-
-
Movsesian, M.A.1
Bristow, M.R.2
-
17
-
-
0345490696
-
Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure
-
1:CAS:528:DC%2BD3sXptlymsL4%3D 14659793
-
A El-Armouche O Zolk T Rau T Eschenhagen 2003 Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure Cardiovasc Res 60 478 487 1:CAS:528:DC%2BD3sXptlymsL4%3D 14659793
-
(2003)
Cardiovasc Res
, vol.60
, pp. 478-487
-
-
El-Armouche, A.1
Zolk, O.2
Rau, T.3
Eschenhagen, T.4
-
18
-
-
0034677823
-
Beta-adrenergic receptor signaling: An acute compensatory adjustment-inappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models
-
1:CAS:528:DC%2BD3cXitFWhu7k%3D 10720410
-
SF Vatner DE Vatner CJ Homcy 2000 Beta-adrenergic receptor signaling: an acute compensatory adjustment-inappropriate for the chronic stress of heart failure? Insights from Gsalpha overexpression and other genetically engineered animal models Circ Res 86 502 506 1:CAS:528:DC%2BD3cXitFWhu7k%3D 10720410
-
(2000)
Circ Res
, vol.86
, pp. 502-506
-
-
Vatner, S.F.1
Vatner, D.E.2
Homcy, C.J.3
-
19
-
-
0019982539
-
Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts
-
1:CAS:528:DyaL38XkvV2qsrc%3D 6283349
-
MR Bristow R Ginsburg W Minobe, et al. 1982 Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts N Engl J Med 307 205 211 1:CAS:528:DyaL38XkvV2qsrc%3D 6283349
-
(1982)
N Engl J Med
, vol.307
, pp. 205-211
-
-
Bristow, M.R.1
Ginsburg, R.2
Minobe, W.3
-
20
-
-
0030030791
-
Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: Progressive reduction of beta 1-adrenergic receptor mRNA in heart failure
-
1:CAS:528:DyaK28XhtVOgs74%3D 8522688
-
S Engelhardt M Bohm E Erdmann MJ Lohse 1996 Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure J Am Coll Cardiol 27 146 154 1:CAS:528:DyaK28XhtVOgs74%3D 8522688
-
(1996)
J Am Coll Cardiol
, vol.27
, pp. 146-154
-
-
Engelhardt, S.1
Bohm, M.2
Erdmann, E.3
Lohse, M.J.4
-
21
-
-
0027497584
-
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart
-
1:STN:280:DyaK3s7ksFCmug%3D%3D 8381058
-
M Ungerer M Bohm JS Elce E Erdmann MJ Lohse 1993 Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart Circulation 87 454 463 1:STN:280:DyaK3s7ksFCmug%3D%3D 8381058
-
(1993)
Circulation
, vol.87
, pp. 454-463
-
-
Ungerer, M.1
Bohm, M.2
Elce, J.S.3
Erdmann, E.4
Lohse, M.J.5
-
22
-
-
40649095214
-
Modulation of cardiac function by A-kinase anchoring proteins
-
1:CAS:528:DC%2BD1cXjtlGksb8%3D 18165153
-
D Diviani 2008 Modulation of cardiac function by A-kinase anchoring proteins Curr Opin Pharmacol 8 166 173 1:CAS:528:DC%2BD1cXjtlGksb8%3D 18165153
-
(2008)
Curr Opin Pharmacol
, vol.8
, pp. 166-173
-
-
Diviani, D.1
-
23
-
-
0034724376
-
Regulation of PKA binding to AKAPs in the heart: Alterations in human heart failure
-
1:CAS:528:DC%2BD3cXis1ShtLg%3D 10736293
-
DR Zakhary CS Moravec M Bond 2000 Regulation of PKA binding to AKAPs in the heart: alterations in human heart failure Circulation 101 1459 1464 1:CAS:528:DC%2BD3cXis1ShtLg%3D 10736293
-
(2000)
Circulation
, vol.101
, pp. 1459-1464
-
-
Zakhary, D.R.1
Moravec, C.S.2
Bond, M.3
-
24
-
-
0013679543
-
On some physiological actions of ergot
-
16992821
-
HH Dale 1906 On some physiological actions of ergot J Physiol 34 163 206 16992821
-
(1906)
J Physiol
, vol.34
, pp. 163-206
-
-
Dale, H.H.1
-
25
-
-
0001244395
-
Studies on the conditions of activity in endocrine organs: XXIX. Sympathin e and sympathin i
-
1:CAS:528:DyaA3sXkslOiug%3D%3D
-
W Cannon A Rosenbueth 1933 Studies on the conditions of activity in endocrine organs: XXIX. Sympathin E and sympathin I Am J Physiol 104 557 574 1:CAS:528:DyaA3sXkslOiug%3D%3D
-
(1933)
Am J Physiol
, vol.104
, pp. 557-574
-
-
Cannon, W.1
Rosenbueth, A.2
-
26
-
-
37149025422
-
Alpha- and beta-adrenergic receptors: Ahlquist's landmark hypothesis of a single mediator with two receptors
-
1:CAS:528:DC%2BD2sXhsVGls73I 17957033
-
DB Bylund 2007 Alpha- and beta-adrenergic receptors: Ahlquist's landmark hypothesis of a single mediator with two receptors Am J Physiol Endocrinol Metab 293 E1479 E1481 1:CAS:528:DC%2BD2sXhsVGls73I 17957033
-
(2007)
Am J Physiol Endocrinol Metab
, vol.293
-
-
Bylund, D.B.1
-
27
-
-
0014197741
-
Development of the concept of alpha and beta adrenotropic receptors
-
1:STN:280:DyaF2s3kvVajsQ%3D%3D 5232333
-
RP Ahlquist 1967 Development of the concept of alpha and beta adrenotropic receptors Ann N Y Acad Sci 139 549 552 1:STN:280: DyaF2s3kvVajsQ%3D%3D 5232333
-
(1967)
Ann N y Acad Sci
, vol.139
, pp. 549-552
-
-
Ahlquist, R.P.1
-
28
-
-
84951653316
-
A study of the adrenotropic receptors
-
1:CAS:528:DyaH1MXhtVGl 18882199
-
RP Ahlquist 1948 A study of the adrenotropic receptors Am J Physiol 153 586 600 1:CAS:528:DyaH1MXhtVGl 18882199
-
(1948)
Am J Physiol
, vol.153
, pp. 586-600
-
-
Ahlquist, R.P.1
-
29
-
-
0026519531
-
Subtypes of alpha 1- and alpha 2-adrenergic receptors
-
1:CAS:528:DyaK38XhsVCjs7w%3D 1346768
-
DB Bylund 1992 Subtypes of alpha 1- and alpha 2-adrenergic receptors FASEB J 6 832 839 1:CAS:528:DyaK38XhsVCjs7w%3D 1346768
-
(1992)
FASEB J
, vol.6
, pp. 832-839
-
-
Bylund, D.B.1
-
30
-
-
0029874397
-
Alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling
-
1:CAS:528:DyaK28Xis1ShtL8%3D 8620593
-
RM Graham DM Perez J Hwa MT Piascik 1996 Alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling Circ Res 78 737 749 1:CAS:528:DyaK28Xis1ShtL8%3D 8620593
-
(1996)
Circ Res
, vol.78
, pp. 737-749
-
-
Graham, R.M.1
Perez, D.M.2
Hwa, J.3
Piascik, M.T.4
-
31
-
-
70350513886
-
The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications
-
1:CAS:528:DC%2BD1MXhsFSqurrL 19874988
-
F Triposkiadis G Karayannis G Giamouzis J Skoularigis G Louridas J Butler 2009 The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications J Am Coll Cardiol 54 1747 1762 1:CAS:528:DC%2BD1MXhsFSqurrL 19874988
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 1747-1762
-
-
Triposkiadis, F.1
Karayannis, G.2
Giamouzis, G.3
Skoularigis, J.4
Louridas, G.5
Butler, J.6
-
32
-
-
0033547241
-
Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission
-
1:CAS:528:DyaK1MXnsVektL0%3D 10647009
-
L Hein JD Altman BK Kobilka 1999 Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission Nature 402 181 184 1:CAS:528:DyaK1MXnsVektL0%3D 10647009
-
(1999)
Nature
, vol.402
, pp. 181-184
-
-
Hein, L.1
Altman, J.D.2
Kobilka, B.K.3
-
33
-
-
0031594991
-
Distribution of alpha1-adrenergic receptor mRNA species in rat heart
-
1:CAS:528:DyaK1cXkt12itb4%3D 9676730
-
DW Wolff HK Dang MF Liu WB Jeffries MA Scofield 1998 Distribution of alpha1-adrenergic receptor mRNA species in rat heart J Cardiovasc Pharmacol 32 117 122 1:CAS:528:DyaK1cXkt12itb4%3D 9676730
-
(1998)
J Cardiovasc Pharmacol
, vol.32
, pp. 117-122
-
-
Wolff, D.W.1
Dang, H.K.2
Liu, M.F.3
Jeffries, W.B.4
Scofield, M.A.5
-
34
-
-
0035903243
-
Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy
-
1:CAS:528:DC%2BD3MXmsVeqsbY%3D 11509451
-
F Lin WA Owens S Chen, et al. 2001 Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy Circ Res 89 343 350 1:CAS:528:DC%2BD3MXmsVeqsbY%3D 11509451
-
(2001)
Circ Res
, vol.89
, pp. 343-350
-
-
Lin, F.1
Owens, W.A.2
Chen, S.3
-
35
-
-
11444270757
-
Alpha1a- but not alpha1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism
-
1:CAS:528:DC%2BD2MXitValtg%3D%3D 15639483
-
BR Rorabaugh SA Ross RJ Gaivin, et al. 2005 Alpha1a- but not alpha1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism Cardiovasc Res 65 436 445 1:CAS:528:DC%2BD2MXitValtg%3D%3D 15639483
-
(2005)
Cardiovasc Res
, vol.65
, pp. 436-445
-
-
Rorabaugh, B.R.1
Ross, S.A.2
Gaivin, R.J.3
-
36
-
-
34447521705
-
Roles of alpha1A- and alpha1B-adrenoceptors in heart: Insights from studies of genetically modified mice
-
1:CAS:528:DC%2BD2sXpslOjsrY%3D 17645635
-
EA Woodcock 2007 Roles of alpha1A- and alpha1B-adrenoceptors in heart: insights from studies of genetically modified mice Clin Exp Pharmacol Physiol 34 884 888 1:CAS:528:DC%2BD2sXpslOjsrY%3D 17645635
-
(2007)
Clin Exp Pharmacol Physiol
, vol.34
, pp. 884-888
-
-
Woodcock, E.A.1
-
37
-
-
0032168435
-
Cardiac-specific overexpression of alpha1BAR regulates betaAR activity via molecular crosstalk
-
1:CAS:528:DyaK1cXms1Snu7Y%3D 9769238
-
I Lemire BG Allen H Rindt TE Hebert 1998 Cardiac-specific overexpression of alpha1BAR regulates betaAR activity via molecular crosstalk J Mol Cell Cardiol 30 1827 1839 1:CAS:528:DyaK1cXms1Snu7Y%3D 9769238
-
(1998)
J Mol Cell Cardiol
, vol.30
, pp. 1827-1839
-
-
Lemire, I.1
Allen, B.G.2
Rindt, H.3
Hebert, T.E.4
-
38
-
-
70049083456
-
The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries
-
1:CAS:528:DC%2BD1MXht1GntbbJ 19761933
-
BC Jensen PM Swigart ME Laden T DeMarco C Hoopes PC Simpson 2009 The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries J Am Coll Cardiol 54 1137 1145 1:CAS:528: DC%2BD1MXht1GntbbJ 19761933
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 1137-1145
-
-
Jensen, B.C.1
Swigart, P.M.2
Laden, M.E.3
Demarco, T.4
Hoopes, C.5
Simpson, P.C.6
-
39
-
-
0014098393
-
Hemodynamic studies in cardiogenic shock. Treatment with isoproterenol and metaraminol
-
1:CAS:528:DyaF2sXksVanurw%3D 6026200
-
HJ Smith A Oriol J Morch M McGregor 1967 Hemodynamic studies in cardiogenic shock. Treatment with isoproterenol and metaraminol Circulation 35 1084 1091 1:CAS:528:DyaF2sXksVanurw%3D 6026200
-
(1967)
Circulation
, vol.35
, pp. 1084-1091
-
-
Smith, H.J.1
Oriol, A.2
Morch, J.3
McGregor, M.4
-
40
-
-
0014985304
-
Factors influencing infarct size following experimental coronary artery occlusions
-
1:STN:280:DyaE3M%2Fpt1ynsQ%3D%3D 5540853
-
PR Maroko JK Kjekshus BE Sobel, et al. 1971 Factors influencing infarct size following experimental coronary artery occlusions Circulation 43 67 82 1:STN:280:DyaE3M%2Fpt1ynsQ%3D%3D 5540853
-
(1971)
Circulation
, vol.43
, pp. 67-82
-
-
Maroko, P.R.1
Kjekshus, J.K.2
Sobel, B.E.3
-
41
-
-
0015312285
-
Cardiovascular and renal actions of dopamine: Potential clinical applications
-
1:CAS:528:DyaE38XktVSjtL0%3D 4554480
-
LI Goldberg 1972 Cardiovascular and renal actions of dopamine: potential clinical applications Pharmacol Rev 24 1 29 1:CAS:528:DyaE38XktVSjtL0%3D 4554480
-
(1972)
Pharmacol Rev
, vol.24
, pp. 1-29
-
-
Goldberg, L.I.1
-
42
-
-
0015743037
-
Coronary and myocardial effects of dopamine in the conscious dog: Parasympatholytic augmentation of pressor and inotropic actions
-
1:CAS:528:DyaE2cXhtVeqsrY%3D 4147854
-
SF Vatner RW Millard CB Higgins 1973 Coronary and myocardial effects of dopamine in the conscious dog: parasympatholytic augmentation of pressor and inotropic actions J Pharmacol Exp Ther 187 280 295 1:CAS:528:DyaE2cXhtVeqsrY%3D 4147854
-
(1973)
J Pharmacol Exp Ther
, vol.187
, pp. 280-295
-
-
Vatner, S.F.1
Millard, R.W.2
Higgins, C.B.3
-
43
-
-
0017371881
-
Comparison of dobutamine and dopamine in treatment of severe heart failure
-
324501
-
JD Stoner 3rd JL Bolen DC Harrison 1977 Comparison of dobutamine and dopamine in treatment of severe heart failure Br Heart J 39 536 539 324501
-
(1977)
Br Heart J
, vol.39
, pp. 536-539
-
-
Stoner III, J.D.1
Bolen, J.L.2
Harrison, D.C.3
-
44
-
-
0345019900
-
Dopamine depresses minute ventilation in patients with heart failure
-
9679718
-
P van de Borne R Oren VK Somers 1998 Dopamine depresses minute ventilation in patients with heart failure Circulation 98 126 131 9679718
-
(1998)
Circulation
, vol.98
, pp. 126-131
-
-
Van De Borne, P.1
Oren, R.2
Somers, V.K.3
-
45
-
-
0037454137
-
Heart failure etiology and response to milrinone in decompensated heart failure: Results from the OPTIME-CHF study
-
1:CAS:528:DC%2BD3sXislejsLk%3D 12651048
-
GM Felker RL Benza AB Chandler, et al. 2003 Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study J Am Coll Cardiol 41 997 1003 1:CAS:528:DC%2BD3sXislejsLk%3D 12651048
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 997-1003
-
-
Felker, G.M.1
Benza, R.L.2
Chandler, A.B.3
-
46
-
-
0014816486
-
Effects of carotid sinus nerve stimulation on the coronary circulation of the conscious dog
-
1:STN:280:DyaE3c3hslWmtw%3D%3D 4393195
-
SF Vatner D Franklin RL Van Citters E Braunwald 1970 Effects of carotid sinus nerve stimulation on the coronary circulation of the conscious dog Circ Res 27 11 21 1:STN:280:DyaE3c3hslWmtw%3D%3D 4393195
-
(1970)
Circ Res
, vol.27
, pp. 11-21
-
-
Vatner, S.F.1
Franklin, D.2
Van Citters, R.L.3
Braunwald, E.4
-
47
-
-
0015318885
-
Extent of carotid sinus regulation of the myocardial contractile state in conscious dogs
-
1:STN:280:DyaE387ktlaqsA%3D%3D 4622571
-
SF Vatner CB Higgins D Franklin E Braunwald 1972 Extent of carotid sinus regulation of the myocardial contractile state in conscious dogs J Clin Invest 51 995 1008 1:STN:280:DyaE387ktlaqsA%3D%3D 4622571
-
(1972)
J Clin Invest
, vol.51
, pp. 995-1008
-
-
Vatner, S.F.1
Higgins, C.B.2
Franklin, D.3
Braunwald, E.4
-
48
-
-
0018344538
-
Baroreflex and vagal mechanisms modulating left ventricular contractile responses to sympathomimetic amines in conscious dogs
-
1:CAS:528:DyaE1MXotFeksQ%3D%3D 761303
-
SF Vatner JD Rutherford HR Ochs 1979 Baroreflex and vagal mechanisms modulating left ventricular contractile responses to sympathomimetic amines in conscious dogs Circ Res 44 195 207 1:CAS:528:DyaE1MXotFeksQ%3D%3D 761303
-
(1979)
Circ Res
, vol.44
, pp. 195-207
-
-
Vatner, S.F.1
Rutherford, J.D.2
Ochs, H.R.3
-
49
-
-
25144443006
-
Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes
-
1:CAS:528:DC%2BD2MXhtFars7nO 16181823
-
M Bayram L De Luca MB Massie M Gheorghiade 2005 Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes Am J Cardiol 96 47G 58G 1:CAS:528:DC%2BD2MXhtFars7nO 16181823
-
(2005)
Am J Cardiol
, vol.96
-
-
Bayram, M.1
De Luca, L.2
Massie, M.B.3
Gheorghiade, M.4
-
50
-
-
0017560516
-
Dopamine in the treatment of heart failure
-
264198
-
AJ Miller 1977 Dopamine in the treatment of heart failure Proc R Soc Med 70 Suppl 2 16 24 264198
-
(1977)
Proc R Soc Med
, vol.70
, Issue.SUPPL. 2
, pp. 16-24
-
-
Miller, A.J.1
-
51
-
-
0016613520
-
Dobutamine: Development of a new catecholamine to selectively increase cardiac contractility
-
1:CAS:528:DyaE2MXksFeiurc%3D 234805
-
RR Tuttle J Mills 1975 Dobutamine: development of a new catecholamine to selectively increase cardiac contractility Circ Res 36 185 196 1:CAS:528:DyaE2MXksFeiurc%3D 234805
-
(1975)
Circ Res
, vol.36
, pp. 185-196
-
-
Tuttle, R.R.1
Mills, J.2
-
52
-
-
0020682982
-
Hemodynamic, hormonal and electrolyte responses to prenalterol infusion in heart failure
-
1:STN:280:DyaL3s7gtlCnsw%3D%3D 6821903
-
D Fitzpatrick H Ikram MG Nicholls EA Espiner 1983 Hemodynamic, hormonal and electrolyte responses to prenalterol infusion in heart failure Circulation 67 613 619 1:STN:280:DyaL3s7gtlCnsw%3D%3D 6821903
-
(1983)
Circulation
, vol.67
, pp. 613-619
-
-
Fitzpatrick, D.1
Ikram, H.2
Nicholls, M.G.3
Espiner, E.A.4
-
53
-
-
0021192117
-
Acute haemodynamic effects of oral prenalterol in severe heart failure
-
1:STN:280:DyaL2c3lslaitw%3D%3D 6146324
-
MC Petch C Wisbey O Ormerod C Scott RM Goodfellow 1984 Acute haemodynamic effects of oral prenalterol in severe heart failure Br Heart J 52 49 52 1:STN:280:DyaL2c3lslaitw%3D%3D 6146324
-
(1984)
Br Heart J
, vol.52
, pp. 49-52
-
-
Petch, M.C.1
Wisbey, C.2
Ormerod, O.3
Scott, C.4
Goodfellow, R.M.5
-
54
-
-
0021320662
-
Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure
-
1:STN:280:DyaL2c%2Fot1GnsA%3D%3D 6140091
-
H Lambertz J Meyer R Erbel 1984 Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure Circulation 69 298 305 1:STN:280:DyaL2c%2Fot1GnsA%3D%3D 6140091
-
(1984)
Circulation
, vol.69
, pp. 298-305
-
-
Lambertz, H.1
Meyer, J.2
Erbel, R.3
-
55
-
-
0021868767
-
Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo
-
1:STN:280:DyaL2M%2FpslGrtA%3D%3D 2857088
-
DR Glover CG Wathen RG Murray MC Petch AL Muir WA Littler 1985 Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo Br Heart J 53 208 215 1:STN:280:DyaL2M%2FpslGrtA%3D%3D 2857088
-
(1985)
Br Heart J
, vol.53
, pp. 208-215
-
-
Glover, D.R.1
Wathen, C.G.2
Murray, R.G.3
Petch, M.C.4
Muir, A.L.5
Littler, W.A.6
-
56
-
-
0025279763
-
Xamoterol in severe heart failure
-
The Xamoterol in Severe Heart Failure Study Group
-
The Xamoterol in Severe Heart Failure Study Group (1990) Xamoterol in severe heart failure. Lancet 336:1-6
-
(1990)
Lancet
, vol.336
, pp. 1-6
-
-
-
57
-
-
0032814621
-
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)
-
10385768
-
CM O'Connor WA Gattis BF Uretsky, et al. 1999 Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST) Am Heart J 138 78 86 10385768
-
(1999)
Am Heart J
, vol.138
, pp. 78-86
-
-
O'Connor, C.M.1
Gattis, W.A.2
Uretsky, B.F.3
-
58
-
-
4043171309
-
Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy
-
15302018
-
AP Coletta JG Cleland N Freemantle AL Clark 2004 Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy Eur J Heart Fail 6 673 676 15302018
-
(2004)
Eur J Heart Fail
, vol.6
, pp. 673-676
-
-
Coletta, A.P.1
Cleland, J.G.2
Freemantle, N.3
Clark, A.L.4
-
59
-
-
21344469500
-
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: An analysis from the acute decompensated heart failure national registry (ADHERE)
-
15992636
-
WT Abraham KF Adams GC Fonarow, et al. 2005 In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the acute decompensated heart failure national registry (ADHERE) J Am Coll Cardiol 46 57 64 15992636
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 57-64
-
-
Abraham, W.T.1
Adams, K.F.2
Fonarow, G.C.3
-
60
-
-
0025914806
-
Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: A randomized, double-blind, parallel, placebo-controlled multicenter study
-
1:STN:280:DyaK3MzhtV2mtg%3D%3D 1677368
-
SB Gollub U Elkayam JB Young LW Miller KA Haffey 1991 Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: a randomized, double-blind, parallel, placebo-controlled multicenter study J Am Coll Cardiol 18 383 390 1:STN:280:DyaK3MzhtV2mtg%3D%3D 1677368
-
(1991)
J Am Coll Cardiol
, vol.18
, pp. 383-390
-
-
Gollub, S.B.1
Elkayam, U.2
Young, J.B.3
Miller, L.W.4
Haffey, K.A.5
-
61
-
-
9044226133
-
Intravenous dopexamine in the treatment of acute congestive heart failure: Results of a multicenter, double-blind, placebo-controlled withdrawal study
-
1:STN:280:DyaK2s%2FgtlSntw%3D%3D 8850384
-
H Asanoi S Sasayama T Sakurai, et al. 1995 Intravenous dopexamine in the treatment of acute congestive heart failure: results of a multicenter, double-blind, placebo-controlled withdrawal study Cardiovasc Drugs Ther 9 791 797 1:STN:280:DyaK2s%2FgtlSntw%3D%3D 8850384
-
(1995)
Cardiovasc Drugs Ther
, vol.9
, pp. 791-797
-
-
Asanoi, H.1
Sasayama, S.2
Sakurai, T.3
-
62
-
-
0015522760
-
Improved left ventricular function during nitroprusside infusion in acute myocardial infarction
-
1:STN:280:DyaE3s3jsleltA%3D%3D 4125161
-
JA Franciosa CJ Limas NH Guiha E Rodriguera JN Cohn 1972 Improved left ventricular function during nitroprusside infusion in acute myocardial infarction Lancet 1 650 654 1:STN:280:DyaE3s3jsleltA%3D%3D 4125161
-
(1972)
Lancet
, vol.1
, pp. 650-654
-
-
Franciosa, J.A.1
Limas, C.J.2
Guiha, N.H.3
Rodriguera, E.4
Cohn, J.N.5
-
63
-
-
0016396998
-
Treatment of refractory heart failure with infusion of nitroprusside
-
1:STN:280:DyaE2czgvFOnsg%3D%3D 4855255
-
NH Guiha JN Cohn E Mikulic JA Franciosa CJ Limas 1974 Treatment of refractory heart failure with infusion of nitroprusside N Engl J Med 291 587 592 1:STN:280:DyaE2czgvFOnsg%3D%3D 4855255
-
(1974)
N Engl J Med
, vol.291
, pp. 587-592
-
-
Guiha, N.H.1
Cohn, J.N.2
Mikulic, E.3
Franciosa, J.A.4
Limas, C.J.5
-
64
-
-
0016438577
-
Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance
-
1:STN:280:DyaE2M%2Fpt1eguw%3D%3D 1112013
-
RR Miller LA Vismara R Zelis EA Amsterdam DT Mason 1975 Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance Circulation 51 328 336 1:STN:280:DyaE2M%2Fpt1eguw%3D%3D 1112013
-
(1975)
Circulation
, vol.51
, pp. 328-336
-
-
Miller, R.R.1
Vismara, L.A.2
Zelis, R.3
Amsterdam, E.A.4
Mason, D.T.5
-
65
-
-
33845309146
-
Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure
-
17174645
-
U Elkayam G Tasissa C Binanay, et al. 2007 Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure Am Heart J 153 98 104 17174645
-
(2007)
Am Heart J
, vol.153
, pp. 98-104
-
-
Elkayam, U.1
Tasissa, G.2
Binanay, C.3
-
66
-
-
0022540049
-
Enoximone (MDL 17, 043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy
-
1:STN:280:DyaL28zhvF2qsw%3D%3D 2944369
-
KT Weber JS Janicki MC Jain 1986 Enoximone (MDL 17, 043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy Am J Cardiol 58 589 595 1:STN:280:DyaL28zhvF2qsw%3D%3D 2944369
-
(1986)
Am J Cardiol
, vol.58
, pp. 589-595
-
-
Weber, K.T.1
Janicki, J.S.2
Jain, M.C.3
-
67
-
-
0022493420
-
Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17, 043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy
-
1:STN:280:DyaL283jvFSntw%3D%3D 2940855
-
MJ Likoff S Ulrich A Hakki AS Iskandrian 1986 Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17, 043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy Am J Cardiol 57 1328 1334 1:STN:280: DyaL283jvFSntw%3D%3D 2940855
-
(1986)
Am J Cardiol
, vol.57
, pp. 1328-1334
-
-
Likoff, M.J.1
Ulrich, S.2
Hakki, A.3
Iskandrian, A.S.4
-
68
-
-
0023181926
-
Acute hemodynamic response to low dose enoximone (MDL 17, 043): An oral dose-range study
-
1:STN:280:DyaL2s3psFyhtA%3D%3D 2956870
-
EM Gilbert MR Bristow JW Mason 1987 Acute hemodynamic response to low dose enoximone (MDL 17, 043): an oral dose-range study Am J Cardiol 60 57C 62C 1:STN:280:DyaL2s3psFyhtA%3D%3D 2956870
-
(1987)
Am J Cardiol
, vol.60
-
-
Gilbert, E.M.1
Bristow, M.R.2
Mason, J.W.3
-
69
-
-
0023258825
-
Comparative effects on hemodynamics of enoximone (MDL 17, 043), dobutamine and nitroprusside in severe congestive heart failure
-
1:STN:280:DyaL2s3psFyhtg%3D%3D 2956868
-
E Installe M Gonzalez JL Jacquemart, et al. 1987 Comparative effects on hemodynamics of enoximone (MDL 17, 043), dobutamine and nitroprusside in severe congestive heart failure Am J Cardiol 60 46C 52C 1:STN:280:DyaL2s3psFyhtg%3D%3D 2956868
-
(1987)
Am J Cardiol
, vol.60
-
-
Installe, E.1
Gonzalez, M.2
Jacquemart, J.L.3
-
70
-
-
0023500853
-
Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure
-
1:STN:280:DyaL1c%2Fltlanuw%3D%3D 2960473
-
SK Choraria D Taylor J Pilcher 1987 Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure Circulation 76 1307 1311 1:STN:280:DyaL1c%2Fltlanuw%3D%3D 2960473
-
(1987)
Circulation
, vol.76
, pp. 1307-1311
-
-
Choraria, S.K.1
Taylor, D.2
Pilcher, J.3
-
71
-
-
0023653247
-
Long-term treatment with oral enoximone for chronic congestive heart failure: The European experience
-
1:STN:280:DyaL2s3psFygsA%3D%3D 2956876
-
N Treese R Erbel J Pilcher, et al. 1987 Long-term treatment with oral enoximone for chronic congestive heart failure: the European experience Am J Cardiol 60 85C 90C 1:STN:280:DyaL2s3psFygsA%3D%3D 2956876
-
(1987)
Am J Cardiol
, vol.60
-
-
Treese, N.1
Erbel, R.2
Pilcher, J.3
-
72
-
-
0023196135
-
A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure
-
1:STN:280:DyaL2s3psFyhuw%3D%3D 2956873
-
G Zipperle F Butzer HA Dieterich F Heinrich 1987 A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure Am J Cardiol 60 72C 74C 1:STN:280:DyaL2s3psFyhuw%3D%3D 2956873
-
(1987)
Am J Cardiol
, vol.60
-
-
Zipperle, G.1
Butzer, F.2
Dieterich, H.A.3
Heinrich, F.4
-
73
-
-
0025732883
-
Oral enoximone therapy in chronic heart failure: A placebo-controlled randomized trial. The Western Enoximone Study Group
-
1:STN:280:DyaK3M3gs1ehug%3D%3D 1826806
-
KA Narahara 1991 Oral enoximone therapy in chronic heart failure: a placebo-controlled randomized trial. The Western Enoximone Study Group Am Heart J 121 1471 1479 1:STN:280:DyaK3M3gs1ehug%3D%3D 1826806
-
(1991)
Am Heart J
, vol.121
, pp. 1471-1479
-
-
Narahara, K.A.1
-
74
-
-
0025880402
-
Effects of enoximone on exercise tolerance in patients with mild to moderate heart failure
-
1:STN:280:DyaK3MzhsVClsA%3D%3D 1830450
-
H Itoh K Taniguchi M Doi A Koike A Sakuma 1991 Effects of enoximone on exercise tolerance in patients with mild to moderate heart failure Am J Cardiol 68 360 364 1:STN:280:DyaK3MzhsVClsA%3D%3D 1830450
-
(1991)
Am J Cardiol
, vol.68
, pp. 360-364
-
-
Itoh, H.1
Taniguchi, K.2
Doi, M.3
Koike, A.4
Sakuma, A.5
-
75
-
-
0027402632
-
Long-term outcome of enoximone therapy in patients with refractory heart failure
-
1:STN:280:DyaK3s7ltFWitQ%3D%3D 8427136
-
GW Dec MA Fifer HC Herrmann D Cocca-Spofford MJ Semigran 1993 Long-term outcome of enoximone therapy in patients with refractory heart failure Am Heart J 125 423 429 1:STN:280:DyaK3s7ltFWitQ%3D%3D 8427136
-
(1993)
Am Heart J
, vol.125
, pp. 423-429
-
-
Dec, G.W.1
Fifer, M.A.2
Herrmann, H.C.3
Cocca-Spofford, D.4
Semigran, M.J.5
-
76
-
-
0027267513
-
Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: Improvement in hemodynamic and metabolic profile
-
1:STN:280:DyaK3sznt1Snsw%3D%3D 8364004
-
N Galie A Branzi G Magnani, et al. 1993 Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile Cardiovasc Drugs Ther 7 337 347 1:STN:280:DyaK3sznt1Snsw%3D%3D 8364004
-
(1993)
Cardiovasc Drugs Ther
, vol.7
, pp. 337-347
-
-
Galie, N.1
Branzi, A.2
Magnani, G.3
-
77
-
-
0032080759
-
Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure
-
1:CAS:528:DyaK1cXjt1SgsL0%3D 9581729
-
SF Shakar WT Abraham EM Gilbert, et al. 1998 Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure J Am Coll Cardiol 31 1336 1340 1:CAS:528:DyaK1cXjt1SgsL0%3D 9581729
-
(1998)
J Am Coll Cardiol
, vol.31
, pp. 1336-1340
-
-
Shakar, S.F.1
Abraham, W.T.2
Gilbert, E.M.3
-
78
-
-
0027966175
-
Treatment of severe heart failure: Quantity or quality of life? A trial of enoximone. Enoximone investigators
-
1:STN:280:DyaK2M%2FjtlOjsA%3D%3D 7946771
-
AJ Cowley AM Skene 1994 Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone investigators Br Heart J 72 226 230 1:STN:280:DyaK2M%2FjtlOjsA%3D%3D 7946771
-
(1994)
Br Heart J
, vol.72
, pp. 226-230
-
-
Cowley, A.J.1
Skene, A.M.2
-
79
-
-
70449531838
-
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: The randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
-
1:CAS:528:DC%2BD1MXhsFyrsrzM 19700774
-
M Metra E Eichhorn WT Abraham, et al. 2009 Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials Eur Heart J 30 3015 3026 1:CAS:528:DC%2BD1MXhsFyrsrzM 19700774
-
(2009)
Eur Heart J
, vol.30
, pp. 3015-3026
-
-
Metra, M.1
Eichhorn, E.2
Abraham, W.T.3
-
81
-
-
0016821937
-
Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding
-
1:CAS:528:DyaE2MXkslahtrk%3D 1055427
-
RW Alexander LT Williams RJ Lefkowitz 1975 Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding Proc Natl Acad Sci USA 72 1564 1568 1:CAS:528:DyaE2MXkslahtrk%3D 1055427
-
(1975)
Proc Natl Acad Sci USA
, vol.72
, pp. 1564-1568
-
-
Alexander, R.W.1
Williams, L.T.2
Lefkowitz, R.J.3
-
82
-
-
0030438465
-
Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs
-
1:CAS:528:DyaK28XmtVSisbo%3D 8819531
-
YT Shen P Cervoni T Claus SF Vatner 1996 Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs J Pharmacol Exp Ther 278 1435 1443 1:CAS:528:DyaK28XmtVSisbo%3D 8819531
-
(1996)
J Pharmacol Exp Ther
, vol.278
, pp. 1435-1443
-
-
Shen, Y.T.1
Cervoni, P.2
Claus, T.3
Vatner, S.F.4
-
83
-
-
0026353958
-
Pathophysiology of the beta-adrenoceptor system in chronic heart failure: Consequences for treatment with agonists, partial agonists or antagonists?
-
1687117
-
OE Brodde 1991 Pathophysiology of the beta-adrenoceptor system in chronic heart failure: consequences for treatment with agonists, partial agonists or antagonists? Eur Heart J 12 Suppl F 54 62 1687117
-
(1991)
Eur Heart J
, vol.12
, Issue.SUPPL. F
, pp. 54-62
-
-
Brodde, O.E.1
-
84
-
-
0024994781
-
Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium
-
1:STN:280:DyaK3czit1Kjtg%3D%3D 2164894
-
MR Bristow RE Hershberger JD Port, et al. 1990 Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium Circulation 82 I12 I25 1:STN:280:DyaK3czit1Kjtg%3D%3D 2164894
-
(1990)
Circulation
, vol.82
-
-
Bristow, M.R.1
Hershberger, R.E.2
Port, J.D.3
-
85
-
-
0024562830
-
Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium
-
1:CAS:528:DyaL1MXhslWisLw%3D 2564629
-
MR Bristow RE Hershberger JD Port W Minobe R Rasmussen 1989 Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium Mol Pharmacol 35 295 303 1:CAS:528:DyaL1MXhslWisLw%3D 2564629
-
(1989)
Mol Pharmacol
, vol.35
, pp. 295-303
-
-
Bristow, M.R.1
Hershberger, R.E.2
Port, J.D.3
Minobe, W.4
Rasmussen, R.5
-
86
-
-
0025936039
-
Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy
-
1:STN:280:DyaK3Mzls1Khsg%3D%3D 1653120
-
MR Bristow FL Anderson JD Port, et al. 1991 Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy Circulation 84 1024 1039 1:STN:280:DyaK3Mzls1Khsg%3D%3D 1653120
-
(1991)
Circulation
, vol.84
, pp. 1024-1039
-
-
Bristow, M.R.1
Anderson, F.L.2
Port, J.D.3
-
87
-
-
0033607778
-
Overexpression of the cardiac beta(2)-adrenergic receptor and expression of a beta-adrenergic receptor kinase-1 (betaARK1) inhibitor both increase myocardial contractility but have differential effects on susceptibility to ischemic injury
-
1:CAS:528:DyaK1MXns1Ontbo%3D 10571539
-
HR Cross C Steenbergen RJ Lefkowitz WJ Koch E Murphy 1999 Overexpression of the cardiac beta(2)-adrenergic receptor and expression of a beta-adrenergic receptor kinase-1 (betaARK1) inhibitor both increase myocardial contractility but have differential effects on susceptibility to ischemic injury Circ Res 85 1077 1084 1:CAS:528:DyaK1MXns1Ontbo%3D 10571539
-
(1999)
Circ Res
, vol.85
, pp. 1077-1084
-
-
Cross, H.R.1
Steenbergen, C.2
Lefkowitz, R.J.3
Koch, W.J.4
Murphy, E.5
-
88
-
-
0028263498
-
Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor
-
1:CAS:528:DyaK2cXivFSjur4%3D 8160017
-
CA Milano LF Allen HA Rockman, et al. 1994 Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor Science 264 582 586 1:CAS:528:DyaK2cXivFSjur4%3D 8160017
-
(1994)
Science
, vol.264
, pp. 582-586
-
-
Milano, C.A.1
Allen, L.F.2
Rockman, H.A.3
-
89
-
-
0036645306
-
Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts
-
1:CAS:528:DC%2BD38XlvVWit74%3D 12093781
-
HT Tevaearai AD Eckhart GB Walton JR Keys K Wilson WJ Koch 2002 Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts Circulation 106 124 129 1:CAS:528:DC%2BD38XlvVWit74%3D 12093781
-
(2002)
Circulation
, vol.106
, pp. 124-129
-
-
Tevaearai, H.T.1
Eckhart, A.D.2
Walton, G.B.3
Keys, J.R.4
Wilson, K.5
Koch, W.J.6
-
90
-
-
0033033440
-
Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice
-
1:CAS:528:DyaK1MXksFKkt7g%3D 10339599
-
GW Dorn 2nd NM Tepe JN Lorenz WJ Koch SB Liggett 1999 Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice Proc Natl Acad Sci USA 96 6400 6405 1:CAS:528:DyaK1MXksFKkt7g%3D 10339599
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 6400-6405
-
-
Dorn II, G.W.1
Tepe, N.M.2
Lorenz, J.N.3
Koch, W.J.4
Liggett, S.B.5
-
91
-
-
0034636061
-
Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: Critical role for expression level
-
1:CAS:528:DC%2BD3cXjtF2ntr8%3D 10758054
-
SB Liggett NM Tepe JN Lorenz, et al. 2000 Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level Circulation 101 1707 1714 1:CAS:528:DC%2BD3cXjtF2ntr8%3D 10758054
-
(2000)
Circulation
, vol.101
, pp. 1707-1714
-
-
Liggett, S.B.1
Tepe, N.M.2
Lorenz, J.N.3
-
92
-
-
0024516573
-
Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy
-
1:STN:280:DyaL1M7js1Wlsw%3D%3D 2537158
-
SM Heilbrunn P Shah MR Bristow HA Valantine R Ginsburg MB Fowler 1989 Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy Circulation 79 483 490 1:STN:280: DyaL1M7js1Wlsw%3D%3D 2537158
-
(1989)
Circulation
, vol.79
, pp. 483-490
-
-
Heilbrunn, S.M.1
Shah, P.2
Bristow, M.R.3
Valantine, H.A.4
Ginsburg, R.5
Fowler, M.B.6
-
93
-
-
0035964246
-
Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance
-
1:CAS:528:DC%2BD3MXntlKis7w%3D 11524394
-
H Kubo KB Margulies V Piacentino 3rd JP Gaughan SR Houser 2001 Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance Circulation 104 1012 1018 1:CAS:528:DC%2BD3MXntlKis7w%3D 11524394
-
(2001)
Circulation
, vol.104
, pp. 1012-1018
-
-
Kubo, H.1
Margulies, K.B.2
Piacentino III, V.3
Gaughan, J.P.4
Houser, S.R.5
-
94
-
-
0037007679
-
Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents
-
1:CAS:528:DC%2BD38Xjt1Shs7g%3D 11986409
-
BD Lowes EM Gilbert WT Abraham, et al. 2002 Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents N Engl J Med 346 1357 1365 1:CAS:528:DC%2BD38Xjt1Shs7g%3D 11986409
-
(2002)
N Engl J Med
, vol.346
, pp. 1357-1365
-
-
Lowes, B.D.1
Gilbert, E.M.2
Abraham, W.T.3
-
95
-
-
20644467055
-
Cardiomyopathy induced by cardiac Gs alpha overexpression
-
1:CAS:528:DyaK2sXht1Wlt7c%3D 9038982
-
M Iwase M Uechi DE Vatner, et al. 1997 Cardiomyopathy induced by cardiac Gs alpha overexpression Am J Physiol 272 H585 H589 1:CAS:528:DyaK2sXht1Wlt7c%3D 9038982
-
(1997)
Am J Physiol
, vol.272
-
-
Iwase, M.1
Uechi, M.2
Vatner, D.E.3
-
96
-
-
0032482754
-
Cardiac Gsalpha overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway
-
1:CAS:528:DyaK1cXltlCltrc%3D 9689139
-
AS Lader YF Xiao Y Ishikawa, et al. 1998 Cardiac Gsalpha overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway Proc Natl Acad Sci USA 95 9669 9674 1:CAS:528:DyaK1cXltlCltrc%3D 9689139
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 9669-9674
-
-
Lader, A.S.1
Xiao, Y.F.2
Ishikawa, Y.3
-
97
-
-
0029912925
-
Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression
-
1:CAS:528:DyaK28XhvVynur4%3D 8635208
-
M Iwase SP Bishop M Uechi, et al. 1996 Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression Circ Res 78 517 524 1:CAS:528:DyaK28XhvVynur4%3D 8635208
-
(1996)
Circ Res
, vol.78
, pp. 517-524
-
-
Iwase, M.1
Bishop, S.P.2
Uechi, M.3
-
98
-
-
0032699668
-
Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse
-
1:CAS:528:DyaK1MXlvFCitbs%3D 10487769
-
K Asai GP Yang YJ Geng, et al. 1999 Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse J Clin Invest 104 551 558 1:CAS:528:DyaK1MXlvFCitbs%3D 10487769
-
(1999)
J Clin Invest
, vol.104
, pp. 551-558
-
-
Asai, K.1
Yang, G.P.2
Geng, Y.J.3
-
99
-
-
0033593633
-
Apoptosis of cardiac myocytes in Gsalpha transgenic mice
-
1:CAS:528:DyaK1MXmslGitw%3D%3D 9915772
-
YJ Geng Y Ishikawa DE Vatner, et al. 1999 Apoptosis of cardiac myocytes in Gsalpha transgenic mice Circ Res 84 34 42 1:CAS:528:DyaK1MXmslGitw%3D%3D 9915772
-
(1999)
Circ Res
, vol.84
, pp. 34-42
-
-
Geng, Y.J.1
Ishikawa, Y.2
Vatner, D.E.3
-
100
-
-
0033535942
-
Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice
-
1:CAS:528:DyaK1MXks1Wktbs%3D 10359838
-
S Engelhardt L Hein F Wiesmann MJ Lohse 1999 Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice Proc Natl Acad Sci USA 96 7059 7064 1:CAS:528:DyaK1MXks1Wktbs%3D 10359838
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 7059-7064
-
-
Engelhardt, S.1
Hein, L.2
Wiesmann, F.3
Lohse, M.J.4
-
101
-
-
0033710840
-
Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing beta(2)-adrenergic receptors in the heart
-
1:CAS:528:DC%2BD3cXot1yhsbs%3D 11090840
-
XJ Du XM Gao B Wang GL Jennings EA Woodcock AM Dart 2000 Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing beta(2)-adrenergic receptors in the heart Cardiovasc Res 48 448 454 1:CAS:528:DC%2BD3cXot1yhsbs%3D 11090840
-
(2000)
Cardiovasc Res
, vol.48
, pp. 448-454
-
-
Du, X.J.1
Gao, X.M.2
Wang, B.3
Jennings, G.L.4
Woodcock, E.A.5
Dart, A.M.6
-
102
-
-
0032578406
-
Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway
-
1:CAS:528:DyaK1cXmslCntrY%3D 9751683
-
C Communal K Singh DR Pimentel WS Colucci 1998 Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway Circulation 98 1329 1334 1:CAS:528:DyaK1cXmslCntrY%3D 9751683
-
(1998)
Circulation
, vol.98
, pp. 1329-1334
-
-
Communal, C.1
Singh, K.2
Pimentel, D.R.3
Colucci, W.S.4
-
103
-
-
0032729995
-
Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: Role of a pertussis toxin-sensitive G protein
-
1:CAS:528:DyaK1MXotVCiu7c%3D 10577992
-
C Communal K Singh DB Sawyer WS Colucci 1999 Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein Circulation 100 2210 2212 1:CAS:528:DyaK1MXotVCiu7c%3D 10577992
-
(1999)
Circulation
, vol.100
, pp. 2210-2212
-
-
Communal, C.1
Singh, K.2
Sawyer, D.B.3
Colucci, W.S.4
-
104
-
-
0034682578
-
Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes
-
1:CAS:528:DC%2BD3cXls1Kltbo%3D 10899100
-
M Zaugg W Xu E Lucchinetti SA Shafiq NZ Jamali MA Siddiqui 2000 Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes Circulation 102 344 350 1:CAS:528:DC%2BD3cXls1Kltbo%3D 10899100
-
(2000)
Circulation
, vol.102
, pp. 344-350
-
-
Zaugg, M.1
Xu, W.2
Lucchinetti, E.3
Shafiq, S.A.4
Jamali, N.Z.5
Siddiqui, M.A.6
-
105
-
-
0027481032
-
The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase
-
1:CAS:528:DyaK3sXksVWms74%3D 8463335
-
WJ Koch J Inglese WC Stone RJ Lefkowitz 1993 The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase J Biol Chem 268 8256 8260 1:CAS:528:DyaK3sXksVWms74%3D 8463335
-
(1993)
J Biol Chem
, vol.268
, pp. 8256-8260
-
-
Koch, W.J.1
Inglese, J.2
Stone, W.C.3
Lefkowitz, R.J.4
-
106
-
-
0028670476
-
Direct evidence that Gi-coupled receptor stimulation of mitogen-activated protein kinase is mediated by G beta gamma activation of p21ras
-
1:CAS:528:DyaK2MXivVCrtbc%3D 7809106
-
WJ Koch BE Hawes LF Allen RJ Lefkowitz 1994 Direct evidence that Gi-coupled receptor stimulation of mitogen-activated protein kinase is mediated by G beta gamma activation of p21ras Proc Natl Acad Sci USA 91 12706 12710 1:CAS:528:DyaK2MXivVCrtbc%3D 7809106
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 12706-12710
-
-
Koch, W.J.1
Hawes, B.E.2
Allen, L.F.3
Lefkowitz, R.J.4
-
107
-
-
0033593121
-
Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes
-
1:CAS:528:DyaK1MXmslGitA%3D%3D 9915773
-
RP Xiao P Avdonin YY Zhou, et al. 1999 Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes Circ Res 84 43 52 1:CAS:528:DyaK1MXmslGitA%3D%3D 9915773
-
(1999)
Circ Res
, vol.84
, pp. 43-52
-
-
Xiao, R.P.1
Avdonin, P.2
Zhou, Y.Y.3
-
108
-
-
0033515118
-
Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy
-
1:CAS:528:DyaK1MXisVWksro%3D 10092665
-
Y Zou I Komuro T Yamazaki, et al. 1999 Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy J Biol Chem 274 9760 9770 1:CAS:528:DyaK1MXisVWksro%3D 10092665
-
(1999)
J Biol Chem
, vol.274
, pp. 9760-9770
-
-
Zou, Y.1
Komuro, I.2
Yamazaki, T.3
-
109
-
-
15444370210
-
Beta2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle
-
1:CAS:528:DC%2BD2MXjt1Wgsb4%3D 15591297
-
JG Burniston LB Tan DF Goldspink 2005 beta2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle J Appl Physiol 98 1379 1386 1:CAS:528:DC%2BD2MXjt1Wgsb4%3D 15591297
-
(2005)
J Appl Physiol
, vol.98
, pp. 1379-1386
-
-
Burniston, J.G.1
Tan, L.B.2
Goldspink, D.F.3
-
110
-
-
0028175901
-
Beta 2-adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+ dynamics, contractility, or phospholamban phosphorylation
-
1:CAS:528:DyaK2cXltVSmsr0%3D 8034672
-
RP Xiao C Hohl R Altschuld, et al. 1994 Beta 2-adrenergic receptor-stimulated increase in cAMP in rat heart cells is not coupled to changes in Ca2+ dynamics, contractility, or phospholamban phosphorylation J Biol Chem 269 19151 19156 1:CAS:528:DyaK2cXltVSmsr0%3D 8034672
-
(1994)
J Biol Chem
, vol.269
, pp. 19151-19156
-
-
Xiao, R.P.1
Hohl, C.2
Altschuld, R.3
-
111
-
-
0027250720
-
Beta 1-adrenoceptor stimulation and beta 2-adrenoceptor stimulation differ in their effects on contraction, cytosolic Ca2+, and Ca2+ current in single rat ventricular cells
-
1:CAS:528:DyaK3sXltlaiurc%3D 8101141
-
RP Xiao EG Lakatta 1993 Beta 1-adrenoceptor stimulation and beta 2-adrenoceptor stimulation differ in their effects on contraction, cytosolic Ca2+, and Ca2+ current in single rat ventricular cells Circ Res 73 286 300 1:CAS:528:DyaK3sXltlaiurc%3D 8101141
-
(1993)
Circ Res
, vol.73
, pp. 286-300
-
-
Xiao, R.P.1
Lakatta, E.G.2
-
112
-
-
0141591523
-
The PDZ-binding motif of the beta2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes
-
1:CAS:528:DC%2BD3sXnslyntrg%3D 12954981
-
Y Xiang B Kobilka 2003 The PDZ-binding motif of the beta2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes Proc Natl Acad Sci USA 100 10776 10781 1:CAS:528:DC%2BD3sXnslyntrg%3D 12954981
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 10776-10781
-
-
Xiang, Y.1
Kobilka, B.2
-
113
-
-
0034874204
-
Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice
-
1:CAS:528:DC%2BD3MXmtFams78%3D 11502890
-
E Devic Y Xiang D Gould B Kobilka 2001 Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice Mol Pharmacol 60 577 583 1:CAS:528: DC%2BD3MXmtFams78%3D 11502890
-
(2001)
Mol Pharmacol
, vol.60
, pp. 577-583
-
-
Devic, E.1
Xiang, Y.2
Gould, D.3
Kobilka, B.4
-
114
-
-
0028987214
-
Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes
-
1:CAS:528:DyaK2MXktVSlsLg%3D 7870040
-
RP Xiao X Ji EG Lakatta 1995 Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes Mol Pharmacol 47 322 329 1:CAS:528:DyaK2MXktVSlsLg%3D 7870040
-
(1995)
Mol Pharmacol
, vol.47
, pp. 322-329
-
-
Xiao, R.P.1
Ji, X.2
Lakatta, E.G.3
-
115
-
-
0035852634
-
Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes
-
1:CAS:528:DC%2BD3MXhsVWjur0%3D 11171998
-
WZ Zhu M Zheng WJ Koch RJ Lefkowitz BK Kobilka RP Xiao 2001 Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes Proc Natl Acad Sci USA 98 1607 1612 1:CAS:528:DC%2BD3MXhsVWjur0%3D 11171998
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 1607-1612
-
-
Zhu, W.Z.1
Zheng, M.2
Koch, W.J.3
Lefkowitz, R.J.4
Kobilka, B.K.5
Xiao, R.P.6
-
116
-
-
0034623819
-
The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase
-
1:CAS:528:DC%2BD3cXoslyntbY%3D 11110775
-
A Chesley MS Lundberg T Asai, et al. 2000 The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase Circ Res 87 1172 1179 1:CAS:528:DC%2BD3cXoslyntbY%3D 11110775
-
(2000)
Circ Res
, vol.87
, pp. 1172-1179
-
-
Chesley, A.1
Lundberg, M.S.2
Asai, T.3
-
117
-
-
0033851270
-
Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat
-
1:CAS:528:DC%2BD3cXmtFyjsbs%3D 10913016
-
M Schafer K Frischkopf G Taimor HM Piper KD Schluter 2000 Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat Am J Physiol Cell Physiol 279 C495 C503 1:CAS:528:DC%2BD3cXmtFyjsbs%3D 10913016
-
(2000)
Am J Physiol Cell Physiol
, vol.279
-
-
Schafer, M.1
Frischkopf, K.2
Taimor, G.3
Piper, H.M.4
Schluter, K.D.5
-
118
-
-
0034978329
-
Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart
-
1:CAS:528:DC%2BD3MXht1aqtLs%3D 11181023
-
C Morisco DC Zebrowski DE Vatner SF Vatner J Sadoshima 2001 Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart J Mol Cell Cardiol 33 561 573 1:CAS:528:DC%2BD3MXht1aqtLs%3D 11181023
-
(2001)
J Mol Cell Cardiol
, vol.33
, pp. 561-573
-
-
Morisco, C.1
Zebrowski, D.C.2
Vatner, D.E.3
Vatner, S.F.4
Sadoshima, J.5
-
119
-
-
34248216911
-
Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor
-
1:CAS:528:DC%2BD2sXlt1OmtLg%3D 17446930
-
PS Peter JE Brady L Yan, et al. 2007 Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor J Clin Invest 117 1335 1343 1:CAS:528: DC%2BD2sXlt1OmtLg%3D 17446930
-
(2007)
J Clin Invest
, vol.117
, pp. 1335-1343
-
-
Peter, P.S.1
Brady, J.E.2
Yan, L.3
-
120
-
-
0033618343
-
G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling
-
1:CAS:528:DyaK1MXltVymtbY%3D 10419531
-
M Kuschel YY Zhou H Cheng, et al. 1999 G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling J Biol Chem 274 22048 22052 1:CAS:528:DyaK1MXltVymtbY%3D 10419531
-
(1999)
J Biol Chem
, vol.274
, pp. 22048-22052
-
-
Kuschel, M.1
Zhou, Y.Y.2
Cheng, H.3
-
121
-
-
0033729377
-
G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels
-
1:STN:280:DC%2BD3M%2FotFaltA%3D%3D 11053129
-
Y Chen-Izu RP Xiao LT Izu, et al. 2000 G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca(2+) channels Biophys J 79 2547 2556 1:STN:280:DC%2BD3M%2FotFaltA%3D%3D 11053129
-
(2000)
Biophys J
, vol.79
, pp. 2547-2556
-
-
Chen-Izu, Y.1
Xiao, R.P.2
Izu, L.T.3
-
122
-
-
0036500494
-
Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes
-
1:CAS:528:DC%2BD38Xhslehs7s%3D 11872839
-
M Zaccolo T Pozzan 2002 Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes Science 295 1711 1715 1:CAS:528:DC%2BD38Xhslehs7s%3D 11872839
-
(2002)
Science
, vol.295
, pp. 1711-1715
-
-
Zaccolo, M.1
Pozzan, T.2
-
123
-
-
33750910207
-
Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling
-
1:CAS:528:DC%2BD28XhtFKgurrF 17038640
-
VO Nikolaev M Bunemann E Schmitteckert MJ Lohse S Engelhardt 2006 Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic receptor-mediated signaling Circ Res 99 1084 1091 1:CAS:528:DC%2BD28XhtFKgurrF 17038640
-
(2006)
Circ Res
, vol.99
, pp. 1084-1091
-
-
Nikolaev, V.O.1
Bunemann, M.2
Schmitteckert, E.3
Lohse, M.J.4
Engelhardt, S.5
-
124
-
-
77950286813
-
Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation
-
1:CAS:528:DC%2BC3cXjslaqsLs%3D 20185685
-
VO Nikolaev A Moshkov AR Lyon, et al. 2010 Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation Science 327 1653 1657 1:CAS:528:DC%2BC3cXjslaqsLs%3D 20185685
-
(2010)
Science
, vol.327
, pp. 1653-1657
-
-
Nikolaev, V.O.1
Moshkov, A.2
Lyon, A.R.3
-
125
-
-
0018337894
-
Phosphorylation-dephosphorylation of enzymes
-
1:CAS:528:DyaE1MXltVCitbY%3D 38740
-
EG Krebs JA Beavo 1979 Phosphorylation-dephosphorylation of enzymes Annu Rev Biochem 48 923 959 1:CAS:528:DyaE1MXltVCitbY%3D 38740
-
(1979)
Annu Rev Biochem
, vol.48
, pp. 923-959
-
-
Krebs, E.G.1
Beavo, J.A.2
-
126
-
-
0031622703
-
Cyclic AMP, PKA, and the physiological regulation of adiposity
-
1:CAS:528:DyaK1cXnsFSqurc%3D 9769707 discussion 160-131
-
GS McKnight DE Cummings PS Amieux, et al. 1998 Cyclic AMP, PKA, and the physiological regulation of adiposity Recent Prog Horm Res 53 139 159 1:CAS:528:DyaK1cXnsFSqurc%3D 9769707 discussion 160-131
-
(1998)
Recent Prog Horm Res
, vol.53
, pp. 139-159
-
-
McKnight, G.S.1
Cummings, D.E.2
Amieux, P.S.3
-
127
-
-
0035941418
-
Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a
-
1:CAS:528:DC%2BD3MXovFGiu7s%3D 11717156
-
CL Antos N Frey SO Marx, et al. 2001 Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a Circ Res 89 997 1004 1:CAS:528:DC%2BD3MXovFGiu7s%3D 11717156
-
(2001)
Circ Res
, vol.89
, pp. 997-1004
-
-
Antos, C.L.1
Frey, N.2
Marx, S.O.3
-
128
-
-
77955685263
-
Abstract 5936: Inhibition of Type 5 adenylyl cyclase rescues cardiomyopathy induced by overexpressed beta2-adrenergic receptors in the heart
-
Yan L, Dillinger J, Williams JG et al (2009) Abstract 5936: Inhibition of Type 5 adenylyl cyclase rescues cardiomyopathy induced by overexpressed beta2-adrenergic receptors in the heart. Circulation S1178
-
(2009)
Circulation
-
-
Yan, L.1
Dillinger, J.2
Williams, J.G.3
-
129
-
-
0032776403
-
Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial
-
1:CAS:528:DyaK1MXlsFegt7k%3D 10426835
-
F Oliva R Latini A Politi, et al. 1999 Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial Am Heart J 138 247 253 1:CAS:528:DyaK1MXlsFegt7k%3D 10426835
-
(1999)
Am Heart J
, vol.138
, pp. 247-253
-
-
Oliva, F.1
Latini, R.2
Politi, A.3
-
130
-
-
0026072848
-
Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group
-
1:STN:280:DyaK38%2FkvFGlsQ%3D%3D 1944425
-
M Packer JR Carver RJ Rodeheffer, et al. 1991 Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group N Engl J Med 325 1468 1475 1:STN:280:DyaK38%2FkvFGlsQ%3D%3D 1944425
-
(1991)
N Engl J Med
, vol.325
, pp. 1468-1475
-
-
Packer, M.1
Carver, J.R.2
Rodeheffer, R.J.3
-
131
-
-
0029937949
-
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. carvedilol heart failure study group
-
1:CAS:528:DyaK28Xjs1Wjtbw%3D 8614419
-
M Packer MR Bristow JN Cohn, et al. 1996 The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. carvedilol heart failure study group N Engl J Med 334 1349 1355 1:CAS:528: DyaK28Xjs1Wjtbw%3D 8614419
-
(1996)
N Engl J Med
, vol.334
, pp. 1349-1355
-
-
Packer, M.1
Bristow, M.R.2
Cohn, J.N.3
-
132
-
-
0032558449
-
Clinical effects of beta-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled, randomized trials
-
1:CAS:528:DyaK1cXmtlOmur0%3D 9743509
-
P Lechat M Packer S Chalon M Cucherat T Arab JP Boissel 1998 Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials Circulation 98 1184 1191 1:CAS:528:DyaK1cXmtlOmur0%3D 9743509
-
(1998)
Circulation
, vol.98
, pp. 1184-1191
-
-
Lechat, P.1
Packer, M.2
Chalon, S.3
Cucherat, M.4
Arab, T.5
Boissel, J.P.6
-
133
-
-
0016243134
-
Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol
-
1:STN:280:DyaE2M7gvFSktg%3D%3D 4451589
-
F Waagstein AC Hjalmarson HS Wasir 1974 Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol Br Heart J 36 1109 1121 1:STN:280:DyaE2M7gvFSktg%3D%3D 4451589
-
(1974)
Br Heart J
, vol.36
, pp. 1109-1121
-
-
Waagstein, F.1
Hjalmarson, A.C.2
Wasir, H.S.3
-
134
-
-
0027135308
-
Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in dilated cardiomyopathy (MDC) trial study group
-
1:STN:280:DyaK2c%2Fms1Kisw%3D%3D 7902479
-
F Waagstein MR Bristow K Swedberg, et al. 1993 Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in dilated cardiomyopathy (MDC) trial study group Lancet 342 1441 1446 1:STN:280: DyaK2c%2Fms1Kisw%3D%3D 7902479
-
(1993)
Lancet
, vol.342
, pp. 1441-1446
-
-
Waagstein, F.1
Bristow, M.R.2
Swedberg, K.3
-
135
-
-
0028092116
-
A randomized trial of beta-blockade in heart failure
-
The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS investigators and committees
-
(1994) A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS investigators and committees. Circulation 90:1765-1773
-
(1994)
Circulation
, vol.90
, pp. 1765-1773
-
-
-
136
-
-
0029738516
-
Effect of carvedilol on mortality and morbidity in patients with chronic heart failure
-
(1996) Effect of carvedilol on mortality and morbidity in patients with chronic heart failure. Circulation 94:592
-
(1996)
Circulation
, vol.94
, pp. 592
-
-
-
137
-
-
0033514046
-
The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomised trial
-
(1999) The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 353:9-13
-
(1999)
Lancet
, vol.353
, pp. 9-13
-
-
-
138
-
-
0033577411
-
The cardiac insufficiency bisoprolol study II
-
1:STN:280:DyaK1M3jt12htw%3D%3D 10218557
-
A Segev YA Mekori 1999 The cardiac insufficiency bisoprolol study II Lancet 353 1361 1:STN:280:DyaK1M3jt12htw%3D%3D 10218557
-
(1999)
Lancet
, vol.353
, pp. 1361
-
-
Segev, A.1
Mekori, Y.A.2
-
139
-
-
0033577411
-
The cardiac insufficiency bisoprolol study II
-
1:STN:280:DyaK1M3jt12htg%3D%3D 10218556
-
GA Drummond IB Squire 1999 The cardiac insufficiency bisoprolol study II Lancet 353 1361 1:STN:280:DyaK1M3jt12htg%3D%3D 10218556
-
(1999)
Lancet
, vol.353
, pp. 1361
-
-
Drummond, G.A.1
Squire, I.B.2
-
140
-
-
0033577411
-
The cardiac insufficiency bisoprolol study II
-
1:STN:280:DyaK1M3jt12hsQ%3D%3D 10218555
-
PA Poole-Wilson 1999 The cardiac insufficiency bisoprolol study II Lancet 353 1360 1361 1:STN:280:DyaK1M3jt12hsQ%3D%3D 10218555
-
(1999)
Lancet
, vol.353
, pp. 1360-1361
-
-
Poole-Wilson, P.A.1
-
141
-
-
0034104565
-
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group
-
1:CAS:528:DC%2BD3cXitVCktbk%3D 10714728
-
A Hjalmarson S Goldstein B Fagerberg, et al. 2000 Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group JAMA 283 1295 1302 1:CAS:528:DC%2BD3cXitVCktbk%3D 10714728
-
(2000)
JAMA
, vol.283
, pp. 1295-1302
-
-
Hjalmarson, A.1
Goldstein, S.2
Fagerberg, B.3
-
142
-
-
33645518432
-
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the conduit artery function evaluation (CAFE) study
-
1:CAS:528:DC%2BD28XhvVektrg%3D 16476843
-
B Williams PS Lacy SM Thom, et al. 2006 Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study Circulation 113 1213 1225 1:CAS:528:DC%2BD28XhvVektrg%3D 16476843
-
(2006)
Circulation
, vol.113
, pp. 1213-1225
-
-
Williams, B.1
Lacy, P.S.2
Thom, S.M.3
-
143
-
-
33747605611
-
The latest generation of beta-blockers: New pharmacologic properties
-
1:CAS:528:DC%2BD28Xpt1Oku70%3D 16884657
-
ME Pedersen JR Cockcroft 2006 The latest generation of beta-blockers: new pharmacologic properties Curr Hypertens Rep 8 279 286 1:CAS:528: DC%2BD28Xpt1Oku70%3D 16884657
-
(2006)
Curr Hypertens Rep
, vol.8
, pp. 279-286
-
-
Pedersen, M.E.1
Cockcroft, J.R.2
-
144
-
-
34548477190
-
The vasodilatory beta-blockers
-
1:CAS:528:DC%2BD2sXhtVenur7I 17686376
-
ME Pedersen JR Cockcroft 2007 The vasodilatory beta-blockers Curr Hypertens Rep 9 269 277 1:CAS:528:DC%2BD2sXhtVenur7I 17686376
-
(2007)
Curr Hypertens Rep
, vol.9
, pp. 269-277
-
-
Pedersen, M.E.1
Cockcroft, J.R.2
-
145
-
-
0037433183
-
Effects of initiating carvedilol in patients with severe chronic heart failure: Results from the COPERNICUS Study
-
1:CAS:528:DC%2BD3sXht1WisLg%3D 12585949
-
H Krum EB Roecker P Mohacsi, et al. 2003 Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study JAMA 289 712 718 1:CAS:528:DC%2BD3sXht1WisLg%3D 12585949
-
(2003)
JAMA
, vol.289
, pp. 712-718
-
-
Krum, H.1
Roecker, E.B.2
Mohacsi, P.3
-
146
-
-
3142776467
-
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): Randomised controlled trial
-
1:CAS:528:DC%2BD3sXltF2isrs%3D 12853193
-
PA Poole-Wilson K Swedberg JG Cleland, et al. 2003 Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 7 13 1:CAS:528:DC%2BD3sXltF2isrs%3D 12853193
-
(2003)
Lancet
, vol.362
, pp. 7-13
-
-
Poole-Wilson, P.A.1
Swedberg, K.2
Cleland, J.G.3
-
147
-
-
0035808030
-
Beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure
-
1:CAS:528:DC%2BD38XivFaruw%3D%3D 11733405
-
S Reiken M Gaburjakova J Gaburjakova, et al. 2001 Beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure Circulation 104 2843 2848 1:CAS:528:DC%2BD38XivFaruw%3D%3D 11733405
-
(2001)
Circulation
, vol.104
, pp. 2843-2848
-
-
Reiken, S.1
Gaburjakova, M.2
Gaburjakova, J.3
-
148
-
-
13544258730
-
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
-
1:CAS:528:DC%2BD2MXksFCgtbc%3D 15642700
-
MD Flather MC Shibata AJ Coats, et al. 2005 Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 215 225 1:CAS:528:DC%2BD2MXksFCgtbc%3D 15642700
-
(2005)
Eur Heart J
, vol.26
, pp. 215-225
-
-
Flather, M.D.1
Shibata, M.C.2
Coats, A.J.3
-
149
-
-
0346502714
-
Molecular mechanisms of reduced beta-adrenergic signaling in the aged heart as revealed by genomic profiling
-
1:CAS:528:DC%2BD2cXjs1Knt74%3D
-
JG Dobson Jr J Fray JL Leonard RE Pratt 2003 Molecular mechanisms of reduced beta-adrenergic signaling in the aged heart as revealed by genomic profiling Physiol Genom 15 142 147 1:CAS:528:DC%2BD2cXjs1Knt74%3D
-
(2003)
Physiol Genom
, vol.15
, pp. 142-147
-
-
Dobson Jr., J.G.1
Fray, J.2
Leonard, J.L.3
Pratt, R.E.4
-
150
-
-
0028070637
-
Age-related changes in beta-adrenergic neuroeffector systems in the human heart
-
1:CAS:528:DyaK2cXmsVKqs7c%3D 8087932
-
M White R Roden W Minobe, et al. 1994 Age-related changes in beta-adrenergic neuroeffector systems in the human heart Circulation 90 1225 1238 1:CAS:528:DyaK2cXmsVKqs7c%3D 8087932
-
(1994)
Circulation
, vol.90
, pp. 1225-1238
-
-
White, M.1
Roden, R.2
Minobe, W.3
-
151
-
-
0032521152
-
Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases
-
1:CAS:528:DyaK1cXitVWjt7g%3D 9502768
-
RP Xiao ED Tomhave DJ Wang, et al. 1998 Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases J Clin Invest 101 1273 1282 1:CAS:528: DyaK1cXitVWjt7g%3D 9502768
-
(1998)
J Clin Invest
, vol.101
, pp. 1273-1282
-
-
Xiao, R.P.1
Tomhave, E.D.2
Wang, D.J.3
-
152
-
-
0038299420
-
Gender differences on the effects of aging on cardiac and peripheral adrenergic stimulation in old conscious monkeys
-
1:CAS:528:DC%2BD3sXmsVagsr0%3D 12860563
-
G Takagi K Asai SF Vatner, et al. 2003 Gender differences on the effects of aging on cardiac and peripheral adrenergic stimulation in old conscious monkeys Am J Physiol Heart Circ Physiol 285 H527 H534 1:CAS:528: DC%2BD3sXmsVagsr0%3D 12860563
-
(2003)
Am J Physiol Heart Circ Physiol
, vol.285
-
-
Takagi, G.1
Asai, K.2
Vatner, S.F.3
-
153
-
-
0034911718
-
The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN)-rationale and design
-
1:CAS:528:DC%2BD3MXmt1Sjs7w%3D 11504166
-
WJ Remme 2001 The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN)-rationale and design Cardiovasc Drugs Ther 15 69 77 1:CAS:528:DC%2BD3MXmt1Sjs7w%3D 11504166
-
(2001)
Cardiovasc Drugs Ther
, vol.15
, pp. 69-77
-
-
Remme, W.J.1
-
154
-
-
0034916015
-
The EPHESUS trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI heart failure efficacy and survival study
-
1:CAS:528:DC%2BD3MXmt1Sjs70%3D 11504167
-
B Pitt G Williams W Remme, et al. 2001 The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI heart failure efficacy and survival study Cardiovasc Drugs Ther 15 79 87 1:CAS:528:DC%2BD3MXmt1Sjs70%3D 11504167
-
(2001)
Cardiovasc Drugs Ther
, vol.15
, pp. 79-87
-
-
Pitt, B.1
Williams, G.2
Remme, W.3
-
155
-
-
0030887356
-
Adenylyl cyclases: Structure, regulation and function in an enzyme superfamily
-
1:CAS:528:DyaK2sXisFyhs74%3D 9140089
-
J Hanoune Y Pouille E Tzavara, et al. 1997 Adenylyl cyclases: structure, regulation and function in an enzyme superfamily Mol Cell Endocrinol 128 179 194 1:CAS:528:DyaK2sXisFyhs74%3D 9140089
-
(1997)
Mol Cell Endocrinol
, vol.128
, pp. 179-194
-
-
Hanoune, J.1
Pouille, Y.2
Tzavara, E.3
-
156
-
-
0027232606
-
Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases
-
1:CAS:528:DyaK3sXltleqsbs%3D 8330684
-
R Iyengar 1993 Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases FASEB J 7 768 775 1:CAS:528:DyaK3sXltleqsbs%3D 8330684
-
(1993)
FASEB J
, vol.7
, pp. 768-775
-
-
Iyengar, R.1
-
157
-
-
0033082655
-
G protein regulation of adenylate cyclase
-
1:CAS:528:DyaK1MXksVynsr8%3D 10101967
-
WF Simonds 1999 G protein regulation of adenylate cyclase Trends Pharmacol Sci 20 66 73 1:CAS:528:DyaK1MXksVynsr8%3D 10101967
-
(1999)
Trends Pharmacol Sci
, vol.20
, pp. 66-73
-
-
Simonds, W.F.1
-
158
-
-
0029992477
-
Complexity and diversity of mammalian adenylyl cyclases
-
1:CAS:528:DyaK28Xis1erurw%3D 8725398
-
RK Sunahara CW Dessauer AG Gilman 1996 Complexity and diversity of mammalian adenylyl cyclases Annu Rev Pharmacol Toxicol 36 461 480 1:CAS:528:DyaK28Xis1erurw%3D 8725398
-
(1996)
Annu Rev Pharmacol Toxicol
, vol.36
, pp. 461-480
-
-
Sunahara, R.K.1
Dessauer, C.W.2
Gilman, A.G.3
-
159
-
-
0031044250
-
The adenylyl cyclases as integrators of transmembrane signal transduction
-
1:CAS:528:DyaK2sXhsVejsLw%3D 9048648
-
Y Ishikawa CJ Homcy 1997 The adenylyl cyclases as integrators of transmembrane signal transduction Circ Res 80 297 304 1:CAS:528: DyaK2sXhsVejsLw%3D 9048648
-
(1997)
Circ Res
, vol.80
, pp. 297-304
-
-
Ishikawa, Y.1
Homcy, C.J.2
-
160
-
-
0042859792
-
Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation
-
1:CAS:528:DC%2BD3sXmt1Ohsrg%3D 12869393
-
S Okumura J Kawabe A Yatani, et al. 2003 Type 5 adenylyl cyclase disruption alters not only sympathetic but also parasympathetic and calcium-mediated cardiac regulation Circ Res 93 364 371 1:CAS:528: DC%2BD3sXmt1Ohsrg%3D 12869393
-
(2003)
Circ Res
, vol.93
, pp. 364-371
-
-
Okumura, S.1
Kawabe, J.2
Yatani, A.3
-
161
-
-
0033544949
-
Inhibition by calcium of mammalian adenylyl cyclases
-
1:CAS:528:DyaK1MXotVGnsL0%3D 10585428
-
JL Guillou H Nakata DM Cooper 1999 Inhibition by calcium of mammalian adenylyl cyclases J Biol Chem 274 35539 35545 1:CAS:528:DyaK1MXotVGnsL0%3D 10585428
-
(1999)
J Biol Chem
, vol.274
, pp. 35539-35545
-
-
Guillou, J.L.1
Nakata, H.2
Cooper, D.M.3
-
162
-
-
0142153385
-
Molecular and cellular requirements for the regulation of adenylate cyclases by calcium
-
1:CAS:528:DC%2BD3sXnsVyjsbw%3D 14505447
-
DM Cooper 2003 Molecular and cellular requirements for the regulation of adenylate cyclases by calcium Biochem Soc Trans 31 912 915 1:CAS:528: DC%2BD3sXnsVyjsbw%3D 14505447
-
(2003)
Biochem Soc Trans
, vol.31
, pp. 912-915
-
-
Cooper, D.M.1
-
163
-
-
0033554838
-
Altering the receptor-effector ratio by transgenic overexpression of type v adenylyl cyclase: Enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling
-
1:CAS:528:DyaK1MXnsFOmsrk%3D 10600134
-
NM Tepe JN Lorenz A Yatani, et al. 1999 Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling Biochemistry 38 16706 16713 1:CAS:528:DyaK1MXnsFOmsrk%3D 10600134
-
(1999)
Biochemistry
, vol.38
, pp. 16706-16713
-
-
Tepe, N.M.1
Lorenz, J.N.2
Yatani, A.3
-
164
-
-
0032874674
-
Transgenic replacement of type v adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G alpha q overexpressing mouse
-
1:CAS:528:DyaK1MXlvVCgtLk%3D 10481072
-
NM Tepe SB Liggett 1999 Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G alpha q overexpressing mouse FEBS Lett 458 236 240 1:CAS:528: DyaK1MXlvVCgtLk%3D 10481072
-
(1999)
FEBS Lett
, vol.458
, pp. 236-240
-
-
Tepe, N.M.1
Liggett, S.B.2
-
165
-
-
77955700281
-
Abstract 3290: Increased Type 5 adenylyl cyclase expression mediates chronic catecholamine stress via increases in oxidative stress and down-regulation of MnSOD
-
L Lai L Yan CL Hu, et al. 2009 Abstract 3290: increased Type 5 adenylyl cyclase expression mediates chronic catecholamine stress via increases in oxidative stress and down-regulation of MnSOD Circulation 120 S781
-
(2009)
Circulation
, vol.120
, pp. 781
-
-
Lai, L.1
Yan, L.2
Hu, C.L.3
-
166
-
-
0042691820
-
Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload
-
1:CAS:528:DC%2BD3sXmvVeisr8%3D 12904575
-
S Okumura G Takagi J Kawabe, et al. 2003 Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload Proc Natl Acad Sci USA 100 9986 9990 1:CAS:528:DC%2BD3sXmvVeisr8%3D 12904575
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 9986-9990
-
-
Okumura, S.1
Takagi, G.2
Kawabe, J.3
-
167
-
-
37349001294
-
Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress
-
1:CAS:528:DC%2BD2sXhtFersLnJ 17893275
-
S Okumura DE Vatner R Kurotani, et al. 2007 Disruption of type 5 adenylyl cyclase enhances desensitization of cyclic adenosine monophosphate signal and increases Akt signal with chronic catecholamine stress Circulation 116 1776 1783 1:CAS:528:DC%2BD2sXhtFersLnJ 17893275
-
(2007)
Circulation
, vol.116
, pp. 1776-1783
-
-
Okumura, S.1
Vatner, D.E.2
Kurotani, R.3
-
168
-
-
0029811050
-
Beta-adrenoceptor desensitization during the development of canine pacing-induced heart failure
-
1:CAS:528:DyaK28Xls1Onu7w%3D 8886492
-
DE Vatner N Sato Y Ishikawa K Kiuchi RP Shannon SF Vatner 1996 Beta-adrenoceptor desensitization during the development of canine pacing-induced heart failure Clin Exp Pharmacol Physiol 23 688 692 1:CAS:528:DyaK28Xls1Onu7w%3D 8886492
-
(1996)
Clin Exp Pharmacol Physiol
, vol.23
, pp. 688-692
-
-
Vatner, D.E.1
Sato, N.2
Ishikawa, Y.3
Kiuchi, K.4
Shannon, R.P.5
Vatner, S.F.6
-
169
-
-
0024826078
-
Chronic norepinephrine elicits desensitization by uncoupling the beta-receptor
-
1:CAS:528:DyaK3cXkvFaktA%3D%3D 2556443
-
DE Vatner SF Vatner J Nejima, et al. 1989 Chronic norepinephrine elicits desensitization by uncoupling the beta-receptor J Clin Invest 84 1741 1748 1:CAS:528:DyaK3cXkvFaktA%3D%3D 2556443
-
(1989)
J Clin Invest
, vol.84
, pp. 1741-1748
-
-
Vatner, D.E.1
Vatner, S.F.2
Nejima, J.3
-
170
-
-
0003218037
-
Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice
-
1:CAS:528:DyaK1MXitl2ru7k%3D 10096940
-
MH Gao NC Lai DM Roth, et al. 1999 Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice Circulation 99 1618 1622 1:CAS:528:DyaK1MXitl2ru7k%3D 10096940
-
(1999)
Circulation
, vol.99
, pp. 1618-1622
-
-
Gao, M.H.1
Lai, N.C.2
Roth, D.M.3
-
171
-
-
0034619585
-
Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity
-
1:CAS:528:DC%2BD3cXptVSjtb0%3D 11067795
-
NC Lai DM Roth MH Gao, et al. 2000 Intracoronary delivery of adenovirus encoding adenylyl cyclase VI increases left ventricular function and cAMP-generating capacity Circulation 102 2396 2401 1:CAS:528: DC%2BD3cXptVSjtb0%3D 11067795
-
(2000)
Circulation
, vol.102
, pp. 2396-2401
-
-
Lai, N.C.1
Roth, D.M.2
Gao, M.H.3
-
172
-
-
0345120936
-
Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy
-
1:CAS:528:DyaK1MXktlSisb8%3D 10377071
-
DM Roth MH Gao NC Lai, et al. 1999 Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy Circulation 99 3099 3102 1:CAS:528:DyaK1MXktlSisb8%3D 10377071
-
(1999)
Circulation
, vol.99
, pp. 3099-3102
-
-
Roth, D.M.1
Gao, M.H.2
Lai, N.C.3
-
173
-
-
0037161374
-
Adenylyl cyclase increases survival in cardiomyopathy
-
1:CAS:528:DC%2BD38XktFajurY%3D 11997288
-
DM Roth H Bayat JD Drumm, et al. 2002 Adenylyl cyclase increases survival in cardiomyopathy Circulation 105 1989 1994 1:CAS:528:DC%2BD38XktFajurY%3D 11997288
-
(2002)
Circulation
, vol.105
, pp. 1989-1994
-
-
Roth, D.M.1
Bayat, H.2
Drumm, J.D.3
-
174
-
-
33746206024
-
Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction
-
1:CAS:528:DC%2BD28Xnt1agsbg%3D 16864723
-
T Takahashi T Tang NC Lai, et al. 2006 Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction Circulation 114 388 396 1:CAS:528:DC%2BD28Xnt1agsbg%3D 16864723
-
(2006)
Circulation
, vol.114
, pp. 388-396
-
-
Takahashi, T.1
Tang, T.2
Lai, N.C.3
-
175
-
-
37349042536
-
Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling
-
1:CAS:528:DC%2BD2sXhsVCjsrfF 18071070
-
T Tang MH Gao NC Lai, et al. 2008 Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling Circulation 117 61 69 1:CAS:528:DC%2BD2sXhsVCjsrfF 18071070
-
(2008)
Circulation
, vol.117
, pp. 61-69
-
-
Tang, T.1
Gao, M.H.2
Lai, N.C.3
-
176
-
-
77955702308
-
Effects of cardiac overexpression of Type 6 adenylyl cyclase affects on the response to chronic pressure overload
-
in press
-
Guellich A, Gao S, Hong C et al (2010) Effects of cardiac overexpression of Type 6 adenylyl cyclase affects on the response to chronic pressure overload. Am J Physiol Heart Circ Physiol (in press)
-
(2010)
Am J Physiol Heart Circ Physiol
-
-
Guellich, A.1
Gao, S.2
Hong, C.3
-
177
-
-
77949908921
-
Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice
-
1:CAS:528:DC%2BC3cXlvVKhsLs%3D 20359598
-
T Tang NC Lai HK Hammond, et al. 2010 Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice J Am Coll Cardiol 55 1476 1486 1:CAS:528:DC%2BC3cXlvVKhsLs%3D 20359598
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1476-1486
-
-
Tang, T.1
Lai, N.C.2
Hammond, H.K.3
-
178
-
-
41549124900
-
Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice
-
1:CAS:528:DC%2BD1cXks1Gmur4%3D 18402905
-
NC Lai T Tang MH Gao, et al. 2008 Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice J Am Coll Cardiol 51 1490 1497 1:CAS:528:DC%2BD1cXks1Gmur4%3D 18402905
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1490-1497
-
-
Lai, N.C.1
Tang, T.2
Gao, M.H.3
-
179
-
-
0037470488
-
Evolutionary medicine: From dwarf model systems to healthy centenarians?
-
12610293
-
VD Longo CE Finch 2003 Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 299 1342 1346 12610293
-
(2003)
Science
, vol.299
, pp. 1342-1346
-
-
Longo, V.D.1
Finch, C.E.2
-
180
-
-
0034703217
-
Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae
-
1:CAS:528:DC%2BD3cXmvVClsbc%3D 11000115
-
SJ Lin PA Defossez L Guarente 2000 Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae Science 289 2126 2128 1:CAS:528:DC%2BD3cXmvVClsbc%3D 11000115
-
(2000)
Science
, vol.289
, pp. 2126-2128
-
-
Lin, S.J.1
Defossez, P.A.2
Guarente, L.3
-
181
-
-
28244475950
-
Overlapping and distinct functions for a Caenorhabditis elegans SIR2 and DAF-16/FOXO
-
1:CAS:528:DC%2BD2MXht1Ols7vL 16280150
-
Y Wang HA Tissenbaum 2006 Overlapping and distinct functions for a Caenorhabditis elegans SIR2 and DAF-16/FOXO Mech Ageing Dev 127 48 56 1:CAS:528:DC%2BD2MXht1Ols7vL 16280150
-
(2006)
Mech Ageing Dev
, vol.127
, pp. 48-56
-
-
Wang, Y.1
Tissenbaum, H.A.2
-
182
-
-
0035826271
-
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
-
1:CAS:528:DC%2BD3MXitVyqtbg%3D 11242085
-
HA Tissenbaum L Guarente 2001 Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans Nature 410 227 230 1:CAS:528: DC%2BD3MXitVyqtbg%3D 11242085
-
(2001)
Nature
, vol.410
, pp. 227-230
-
-
Tissenbaum, H.A.1
Guarente, L.2
-
183
-
-
8644224064
-
Sir2 mediates longevity in the fly through a pathway related to calorie restriction
-
1:CAS:528:DC%2BD2cXhtVGis77E 15520384
-
B Rogina SL Helfand 2004 Sir2 mediates longevity in the fly through a pathway related to calorie restriction Proc Natl Acad Sci USA 101 15998 16003 1:CAS:528:DC%2BD2cXhtVGis77E 15520384
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 15998-16003
-
-
Rogina, B.1
Helfand, S.L.2
-
184
-
-
22744444561
-
Calorie restriction and SIR2 genes-towards a mechanism
-
1:CAS:528:DC%2BD2MXmvVGjtro%3D 15941577
-
L Guarente 2005 Calorie restriction and SIR2 genes-towards a mechanism Mech Ageing Dev 126 923 928 1:CAS:528:DC%2BD2MXmvVGjtro%3D 15941577
-
(2005)
Mech Ageing Dev
, vol.126
, pp. 923-928
-
-
Guarente, L.1
-
185
-
-
28844469898
-
Increase in activity during calorie restriction requires Sirt1
-
1:CAS:528:DC%2BD2MXhtlahsLbJ 16339438
-
D Chen AD Steele S Lindquist L Guarente 2005 Increase in activity during calorie restriction requires Sirt1 Science 310 1641 1:CAS:528:DC%2BD2MXhtlahsLbJ 16339438
-
(2005)
Science
, vol.310
, pp. 1641
-
-
Chen, D.1
Steele, A.D.2
Lindquist, S.3
Guarente, L.4
-
186
-
-
34447528668
-
Type 5 adenylyl cyclase disruption increases longevity and protects against stress
-
1:CAS:528:DC%2BD2sXovFalt78%3D 17662940
-
L Yan DE Vatner JP O'Connor, et al. 2007 Type 5 adenylyl cyclase disruption increases longevity and protects against stress Cell 130 247 258 1:CAS:528:DC%2BD2sXovFalt78%3D 17662940
-
(2007)
Cell
, vol.130
, pp. 247-258
-
-
Yan, L.1
Vatner, D.E.2
O'Connor, J.P.3
-
187
-
-
77955693194
-
Abstract 1625: Type 5 adenylyl cyclase disruption enhances exercise capacity not due to improved cardiac output, but rather to resistance to oxidative stress in skeletal muscle
-
L Yan JG Williams J Dillinger, et al. 2009 Abstract 1625: Type 5 adenylyl cyclase disruption enhances exercise capacity not due to improved cardiac output, but rather to resistance to oxidative stress in skeletal muscle Circulation 120 S532
-
(2009)
Circulation
, vol.120
, pp. 532
-
-
Yan, L.1
Williams, J.G.2
Dillinger, J.3
-
189
-
-
0037592920
-
Motor dysfunction in type 5 adenylyl cyclase-null mice
-
1:CAS:528:DC%2BD3sXjsVKntbo%3D 12665504
-
T Iwamoto S Okumura K Iwatsubo, et al. 2003 Motor dysfunction in type 5 adenylyl cyclase-null mice J Biol Chem 278 16936 16940 1:CAS:528: DC%2BD3sXjsVKntbo%3D 12665504
-
(2003)
J Biol Chem
, vol.278
, pp. 16936-16940
-
-
Iwamoto, T.1
Okumura, S.2
Iwatsubo, K.3
-
190
-
-
70349620855
-
Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning
-
1:CAS:528:DC%2BD1MXht12qu7zI 19793969
-
MA Kheirbek JP Britt JA Beeler Y Ishikawa DS McGehee X Zhuang 2009 Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning J Neurosci 29 12115 12124 1:CAS:528: DC%2BD1MXht12qu7zI 19793969
-
(2009)
J Neurosci
, vol.29
, pp. 12115-12124
-
-
Kheirbek, M.A.1
Britt, J.P.2
Beeler, J.A.3
Ishikawa, Y.4
McGehee, D.S.5
Zhuang, X.6
-
191
-
-
56149091090
-
A cAMP pathway underlying reward prediction in associative learning
-
1:CAS:528:DC%2BD1cXhtlGlt7%2FN 18971482
-
MA Kheirbek JA Beeler Y Ishikawa X Zhuang 2008 A cAMP pathway underlying reward prediction in associative learning J Neurosci 28 11401 11408 1:CAS:528:DC%2BD1cXhtlGlt7%2FN 18971482
-
(2008)
J Neurosci
, vol.28
, pp. 11401-11408
-
-
Kheirbek, M.A.1
Beeler, J.A.2
Ishikawa, Y.3
Zhuang, X.4
-
192
-
-
70449379427
-
Mice lacking adenylyl cyclase-5 cope badly with repeated restraint stress
-
1:CAS:528:DC%2BD1MXhtVSntb3J 19405150
-
KS Kim PL Han 2009 Mice lacking adenylyl cyclase-5 cope badly with repeated restraint stress J Neurosci Res 87 2983 2993 1:CAS:528: DC%2BD1MXhtVSntb3J 19405150
-
(2009)
J Neurosci Res
, vol.87
, pp. 2983-2993
-
-
Kim, K.S.1
Han, P.L.2
-
193
-
-
51849155046
-
Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior
-
1:CAS:528:DC%2BD1cXht1KgtLbN 18673448
-
KS Kim KW Lee IS Baek, et al. 2008 Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior J Neurochem 107 105 115 1:CAS:528:DC%2BD1cXht1KgtLbN 18673448
-
(2008)
J Neurochem
, vol.107
, pp. 105-115
-
-
Kim, K.S.1
Lee, K.W.2
Baek, I.S.3
-
194
-
-
33847282438
-
Markedly attenuated acute and chronic pain responses in mice lacking adenylyl cyclase-5
-
1:CAS:528:DC%2BD2sXksFWlsrs%3D 17410641
-
KS Kim J Kim SK Back JY Im HS Na PL Han 2007 Markedly attenuated acute and chronic pain responses in mice lacking adenylyl cyclase-5 Genes Brain Behav 6 120 127 1:CAS:528:DC%2BD2sXksFWlsrs%3D 17410641
-
(2007)
Genes Brain Behav
, vol.6
, pp. 120-127
-
-
Kim, K.S.1
Kim, J.2
Back, S.K.3
Im, J.Y.4
Na, H.S.5
Han, P.L.6
-
195
-
-
33644868454
-
Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action
-
1:CAS:528:DC%2BD28XivFWisbc%3D 16537460
-
KS Kim KW Lee JY Im, et al. 2006 Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action Proc Natl Acad Sci USA 103 3908 3913 1:CAS:528:DC%2BD28XivFWisbc%3D 16537460
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 3908-3913
-
-
Kim, K.S.1
Lee, K.W.2
Im, J.Y.3
-
196
-
-
3142727688
-
Brain to blood efflux transport of adenosine: Blood-brain barrier studies in the rat
-
1:CAS:528:DC%2BD2cXmtVyrsbY%3D 15228584
-
AJ Isakovic NJ Abbott ZB Redzic 2004 Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat J Neurochem 90 272 286 1:CAS:528:DC%2BD2cXmtVyrsbY%3D 15228584
-
(2004)
J Neurochem
, vol.90
, pp. 272-286
-
-
Isakovic, A.J.1
Abbott, N.J.2
Redzic, Z.B.3
-
197
-
-
57049090773
-
Metabolism and distribution of 9-Beta-D-arabinofuranosyladenine in mouse tissues
-
1:CAS:528:DyaF2cXksFSnu7w%3D 14195341
-
JJ Brink GA Lepage 1964 Metabolism and distribution of 9-Beta-D-arabinofuranosyladenine in mouse tissues Cancer Res 24 1042 1049 1:CAS:528:DyaF2cXksFSnu7w%3D 14195341
-
(1964)
Cancer Res
, vol.24
, pp. 1042-1049
-
-
Brink, J.J.1
Lepage, G.A.2
-
198
-
-
33845967865
-
Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats
-
1:CAS:528:DC%2BD28XhtlCrt7rL 17079231
-
M Li JF Chiu BT Mossman NK Fukagawa 2006 Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats J Biol Chem 281 40429 40439 1:CAS:528:DC%2BD28XhtlCrt7rL 17079231
-
(2006)
J Biol Chem
, vol.281
, pp. 40429-40439
-
-
Li, M.1
Chiu, J.F.2
Mossman, B.T.3
Fukagawa, N.K.4
-
199
-
-
0025663760
-
Identification of a specialized adenylyl cyclase that may mediate odorant detection
-
1:CAS:528:DyaK3MXlvFegug%3D%3D 2255909
-
HA Bakalyar RR Reed 1990 Identification of a specialized adenylyl cyclase that may mediate odorant detection Science 250 1403 1406 1:CAS:528: DyaK3MXlvFegug%3D%3D 2255909
-
(1990)
Science
, vol.250
, pp. 1403-1406
-
-
Bakalyar, H.A.1
Reed, R.R.2
-
200
-
-
0025720546
-
Molecular cloning and characterization of a Ca2+/calmodulin-insensitive adenylyl cyclase from rat brain
-
1:CAS:528:DyaK3sXjsFSiug%3D%3D 1719547
-
PG Feinstein KA Schrader HA Bakalyar, et al. 1991 Molecular cloning and characterization of a Ca2+/calmodulin-insensitive adenylyl cyclase from rat brain Proc Natl Acad Sci USA 88 10173 10177 1:CAS:528:DyaK3sXjsFSiug%3D%3D 1719547
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 10173-10177
-
-
Feinstein, P.G.1
Schrader, K.A.2
Bakalyar, H.A.3
-
201
-
-
0025719492
-
Cloning and expression of a widely distributed (type IV) adenylyl cyclase
-
1:CAS:528:DyaK3sXhs1CjsL8%3D 1946437
-
BN Gao AG Gilman 1991 Cloning and expression of a widely distributed (type IV) adenylyl cyclase Proc Natl Acad Sci USA 88 10178 10182 1:CAS:528:DyaK3sXhs1CjsL8%3D 1946437
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 10178-10182
-
-
Gao, B.N.1
Gilman, A.G.2
-
202
-
-
0026680815
-
Isolation and characterization of a novel cardiac adenylylcyclase cDNA
-
1:CAS:528:DyaK3sXkvV2mu7Y%3D 1618857
-
Y Ishikawa S Katsushika L Chen NJ Halnon J Kawabe CJ Homcy 1992 Isolation and characterization of a novel cardiac adenylylcyclase cDNA J Biol Chem 267 13553 13557 1:CAS:528:DyaK3sXkvV2mu7Y%3D 1618857
-
(1992)
J Biol Chem
, vol.267
, pp. 13553-13557
-
-
Ishikawa, Y.1
Katsushika, S.2
Chen, L.3
Halnon, N.J.4
Kawabe, J.5
Homcy, C.J.6
-
203
-
-
0026662548
-
Cloning and characterization of a sixth adenylyl cyclase isoform: Types v and VI constitute a subgroup within the mammalian adenylyl cyclase family
-
1:CAS:528:DyaK3sXlsFCkt7c%3D 1528892
-
S Katsushika L Chen J Kawabe, et al. 1992 Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family Proc Natl Acad Sci USA 89 8774 8778 1:CAS:528:DyaK3sXlsFCkt7c%3D 1528892
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 8774-8778
-
-
Katsushika, S.1
Chen, L.2
Kawabe, J.3
-
204
-
-
0026744081
-
Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases
-
1:CAS:528:DyaK3sXkvV2ru74%3D 1409703
-
RT Premont J Chen HW Ma M Ponnapalli R Iyengar 1992 Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases Proc Natl Acad Sci USA 89 9809 9813 1:CAS:528:DyaK3sXkvV2ru74%3D 1409703
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 9809-9813
-
-
Premont, R.T.1
Chen, J.2
Ma, H.W.3
Ponnapalli, M.4
Iyengar, R.5
-
205
-
-
0026684825
-
Cloning and expression of a Ca(2+)-inhibitable adenylyl cyclase from NCB-20 cells
-
1:CAS:528:DyaK3sXktVertbw%3D 1379717
-
M Yoshimura DM Cooper 1992 Cloning and expression of a Ca(2+)-inhibitable adenylyl cyclase from NCB-20 cells Proc Natl Acad Sci USA 89 6716 6720 1:CAS:528:DyaK3sXktVertbw%3D 1379717
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 6716-6720
-
-
Yoshimura, M.1
Cooper, D.M.2
-
206
-
-
0028304648
-
Type VIII adenylyl cyclase. A Ca2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain
-
1:CAS:528:DyaK2cXktVGktL8%3D 8163524
-
JJ Cali JC Zwaagstra N Mons DM Cooper J Krupinski 1994 Type VIII adenylyl cyclase. A Ca2+/calmodulin-stimulated enzyme expressed in discrete regions of rat brain J Biol Chem 269 12190 12195 1:CAS:528:DyaK2cXktVGktL8%3D 8163524
-
(1994)
J Biol Chem
, vol.269
, pp. 12190-12195
-
-
Cali, J.J.1
Zwaagstra, J.C.2
Mons, N.3
Cooper, D.M.4
Krupinski, J.5
-
207
-
-
0027973059
-
Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells
-
1:CAS:528:DyaK2MXhtlWgurk%3D 7961850
-
PA Watson J Krupinski AM Kempinski CD Frankenfield 1994 Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells J Biol Chem 269 28893 28898 1:CAS:528:DyaK2MXhtlWgurk%3D 7961850
-
(1994)
J Biol Chem
, vol.269
, pp. 28893-28898
-
-
Watson, P.A.1
Krupinski, J.2
Kempinski, A.M.3
Frankenfield, C.D.4
-
209
-
-
0017636509
-
Two distinct adenosine-sensitive sites on adenylate cyclase
-
1:CAS:528:DyaE1cXosFWrtQ%3D%3D 271970
-
C Londos J Wolff 1977 Two distinct adenosine-sensitive sites on adenylate cyclase Proc Natl Acad Sci USA 74 5482 5486 1:CAS:528:DyaE1cXosFWrtQ%3D%3D 271970
-
(1977)
Proc Natl Acad Sci USA
, vol.74
, pp. 5482-5486
-
-
Londos, C.1
Wolff, J.2
-
210
-
-
2642664447
-
Role of adenylate cyclase in immunologic release of mediators from rat mast cells: Agonist and antagonist effects of purine- and ribose-modified adenosine analogs
-
1:CAS:528:DyaL3MXksFCktQ%3D%3D 6256761
-
ST Holgate RA Lewis KF Austen 1980 Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs Proc Natl Acad Sci USA 77 6800 6804 1:CAS:528:DyaL3MXksFCktQ%3D%3D 6256761
-
(1980)
Proc Natl Acad Sci USA
, vol.77
, pp. 6800-6804
-
-
Holgate, S.T.1
Lewis, R.A.2
Austen, K.F.3
-
211
-
-
1842335067
-
Isozyme-dependent sensitivity of adenylyl cyclases to P-site-mediated inhibition by adenine nucleosides and nucleoside 3'-polyphosphates
-
1:CAS:528:DyaK2sXisVGrtLg%3D 9083018
-
RA Johnson L Desaubry G Bianchi, et al. 1997 Isozyme-dependent sensitivity of adenylyl cyclases to P-site-mediated inhibition by adenine nucleosides and nucleoside 3'-polyphosphates J Biol Chem 272 8962 8966 1:CAS:528:DyaK2sXisVGrtLg%3D 9083018
-
(1997)
J Biol Chem
, vol.272
, pp. 8962-8966
-
-
Johnson, R.A.1
Desaubry, L.2
Bianchi, G.3
-
212
-
-
2442506761
-
Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides
-
1:CAS:528:DC%2BD2cXjs1Whsr0%3D 14981084
-
A Gille GH Lushington TC Mou MB Doughty RA Johnson R Seifert 2004 Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides J Biol Chem 279 19955 19969 1:CAS:528:DC%2BD2cXjs1Whsr0%3D 14981084
-
(2004)
J Biol Chem
, vol.279
, pp. 19955-19969
-
-
Gille, A.1
Lushington, G.H.2
Mou, T.C.3
Doughty, M.B.4
Johnson, R.A.5
Seifert, R.6
-
213
-
-
34247216741
-
Functional adenylyl cyclase inhibition in murine cardiomyocytes by 2′(3′)-O-(N-methylanthraniloyl)-guanosine 5′-[gamma-thio] triphosphate
-
1:CAS:528:DC%2BD2sXltFehtbc%3D 17284671
-
D Rottlaender J Matthes SF Vatner R Seifert S Herzig 2007 Functional adenylyl cyclase inhibition in murine cardiomyocytes by 2′(3′)-O-(N- methylanthraniloyl)-guanosine 5′-[gamma-thio]triphosphate J Pharmacol Exp Ther 321 608 615 1:CAS:528:DC%2BD2sXltFehtbc%3D 17284671
-
(2007)
J Pharmacol Exp Ther
, vol.321
, pp. 608-615
-
-
Rottlaender, D.1
Matthes, J.2
Vatner, S.F.3
Seifert, R.4
Herzig, S.5
-
215
-
-
4644330950
-
Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration
-
1:CAS:528:DC%2BD2cXnslWnurs%3D 15262973
-
K Iwatsubo S Minamisawa T Tsunematsu, et al. 2004 Direct inhibition of type 5 adenylyl cyclase prevents myocardial apoptosis without functional deterioration J Biol Chem 279 40938 40945 1:CAS:528:DC%2BD2cXnslWnurs%3D 15262973
-
(2004)
J Biol Chem
, vol.279
, pp. 40938-40945
-
-
Iwatsubo, K.1
Minamisawa, S.2
Tsunematsu, T.3
-
216
-
-
0037573314
-
Metal coordination-based inhibitors of adenylyl cyclase: Novel potent P-site antagonists
-
1:CAS:528:DC%2BD3sXjtFagtro%3D 12747789
-
DE Levy M Bao DB Cherbavaz, et al. 2003 Metal coordination-based inhibitors of adenylyl cyclase: novel potent P-site antagonists J Med Chem 46 2177 2186 1:CAS:528:DC%2BD3sXjtFagtro%3D 12747789
-
(2003)
J Med Chem
, vol.46
, pp. 2177-2186
-
-
Levy, D.E.1
Bao, M.2
Cherbavaz, D.B.3
-
217
-
-
0037020720
-
Hydroxamate based inhibitors of adenylyl cyclase. Part 2: The effect of cyclic linkers on P-site binding
-
1:CAS:528:DC%2BD38Xns1Ogs70%3D 12372508
-
D Levy M Bao J Tomlinson R Scarborough 2002 Hydroxamate based inhibitors of adenylyl cyclase. Part 2: the effect of cyclic linkers on P-site binding Bioorg Med Chem Lett 12 3089 3092 1:CAS:528:DC%2BD38Xns1Ogs70%3D 12372508
-
(2002)
Bioorg Med Chem Lett
, vol.12
, pp. 3089-3092
-
-
Levy, D.1
Bao, M.2
Tomlinson, J.3
Scarborough, R.4
-
218
-
-
0037020761
-
Hydroxamate based inhibitors of adenylyl cyclase. Part 1: The effect of acyclic linkers on P-site binding
-
1:CAS:528:DC%2BD38Xns1Ogs7w%3D 12372507
-
D Levy C Marlowe K Kane-Maguire, et al. 2002 Hydroxamate based inhibitors of adenylyl cyclase. Part 1: the effect of acyclic linkers on P-site binding Bioorg Med Chem Lett 12 3085 3088 1:CAS:528:DC%2BD38Xns1Ogs7w%3D 12372507
-
(2002)
Bioorg Med Chem Lett
, vol.12
, pp. 3085-3088
-
-
Levy, D.1
Marlowe, C.2
Kane-Maguire, K.3
-
219
-
-
77955701640
-
Interaction between age and obesity on cardiomyocyte contractile function: Role of leptin and stress signaling
-
20396382
-
J Ren F Dong GJ Cai, et al. 2010 Interaction between age and obesity on cardiomyocyte contractile function: role of leptin and stress signaling PLoS One 5 e10085 20396382
-
(2010)
PLoS One
, vol.5
, pp. 10085
-
-
Ren, J.1
Dong, F.2
Cai, G.J.3
-
220
-
-
0028951035
-
Time coure of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade
-
1:STN:280:DyaK2M3gsVyhsA%3D%3D 7897129
-
SA Hall CG Cigarroa L Marcoux RC Risser PA Grayburn EJ Eichhorn 1995 Time coure of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade J Am Coll Cardiol 25 1154 1161 1:STN:280:DyaK2M3gsVyhsA%3D%3D 7897129
-
(1995)
J Am Coll Cardiol
, vol.25
, pp. 1154-1161
-
-
Hall, S.A.1
Cigarroa, C.G.2
Marcoux, L.3
Risser, R.C.4
Grayburn, P.A.5
Eichhorn, E.J.6
|